Mitochondrial dysfunction in cancer

Frontiers in Oncology

Volumn 3 DEC, Issue , 2013, Pages

  Boland, Michelle L ^a,b   Chourasia, Aparajita H ^a,b   Macleod, Kay F ^a,b  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

Cancer metabolism; Cell cycle control; Mitochondria; Mitochondrial biogenesis; Mitochondrial fusion and fission; Mitophagy; Oxidative phosphorylation

Indexed keywords

APOPTOTIC PROTEASE ACTIVATING FACTOR 1; BETA CATENIN; CASPASE 3; CYCLIN D1; CYCLIN DEPENDENT KINASE INHIBITOR 2A; CYCLIN E; ESTROGEN RELATED RECEPTOR ALPHA; HEXOKINASE; ISOCITRATE DEHYDROGENASE 1; KELCH LIKE ECH ASSOCIATED PROTEIN 1; MITOFUSIN 1; MITOFUSIN 2; MYC PROTEIN; PARKIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PROTEIN BAK; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN KINASE B; PROTEIN KINASE C DELTA; PROTEIN MCL 1; PROTEIN P53; PROTEIN P73; PYRUVATE DEHYDROGENASE KINASE 4; REACTIVE OXYGEN METABOLITE; SIRTUIN 3; TRANSCRIPTION FACTOR E2F; UBIQUITIN PROTEIN LIGASE E3; UNINDEXED DRUG;

APOPTOSIS; AUTOPHAGY; BIOGENESIS; CALCIUM HOMEOSTASIS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL VIABILITY; ENDOPLASMIC RETICULUM; EPIGENETICS; GENE CONTROL; GENE MUTATION; HUMAN; HYPOXIA; MITOCHONDRIAL DYNAMICS; MITOCHONDRION; MITOPHAGY; NEOPLASM; NONHUMAN; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; UNFOLDED PROTEIN RESPONSE;

EID: 84892404204     PISSN: None     EISSN: 2234943X     Source Type: Journal    
DOI: 10.3389/fonc.2013.00292     Document Type: Review

References (408)

1. Chan DC. Mitochondria: dynamic organelles in disease, aging and development. Cell (2006) 125:1241-52. doi: 10.1016/j.cell.2006.06.010.
2. Martinou JC, Youle RJ. Mitochondria in apoptosis:Bcl-2 family members and mitochondrial dynamics. Dev Cell (2011) 21:92-101. doi:10.1016/j.devcel.2011.06.017.
3. Nunnari J, Suomalainen A. Mitochondria: in sickness and in health. Cell (2012) 148:1145-59. doi:10.1016/j.cell.2012.02.035.
4. Wallace DC, Fan WW, Procaccio V. Mitochondrial energetics and therapeutics. Annu Rev Pathol (2010) 5:297-348. doi:10.1146/annurev.pathol.4.110807.092314.
5. Koppenol WH, Bounds PL, Dang CV. Otto Warburg's contributions to current concepts of cancer metabolism. Nat Rev Cancer (2011) 11:325-37. doi:10.1038/nrc3038.
6. Gottlieb E, Tomlinson IPM. Mitochondrial tumour suppressors: a genetic and biochemical update. Nat Rev Cancer (2005) 5:857-66. doi:10.1038/nrc1737.
7. Vander Heiden MG, Cantley LC, Thompson CB. Understanding the Warburg Effect: the metabolic requirements of cell proliferation. Science (2009) 324:1029-33. doi:10.1126/science.1160809.
8. Locasale JW, Grassian AR, Melman T, Lyssiotis CA, Mattaini KR, Bass AJ, et al. Phosphoglycerate dehydrogenase diverts glycolytic flux and contributes to oncogenesis. Nat Genet (2011) 43:869-74. doi:10.1038/ng.890.
9. Possemato R, Marks KM, Shaul YD, Pacold ME, Kim D, Birsoy K, et al. Functional genomics reveal that the serine synthesis pathway is essential in breast cancer. Nature (2011) 476:346-50. doi:10.1038/nature10350.
10. Hitosugi T, Zhou L, Elf S, Fan J, Kang HB, Seo JH, et al. Phosphoglycerate mutase 1 coordinates glycolysis and biosynthesis to promote tumor growth. Cancer Cell (2012) 22:585-600. doi:10.1016/j.ccr.2012.09.020.
11. Vaughn AE, Deshmukh M. Glucose metabolism inhibits apoptosis in neurons and cancer cells by redox inactivation of cytochrome c. Nat Cell Biol (2008) 10:1477-83. doi:10.1038/ncb1807.
12. Cantor JR, Sabatini DM. Cancer cell metabolism: one hallmark, many faces. Cancer Discov (2012) 2:881-98. doi:10.1158/2159-8290.CD-12-0345.
13. Deberardinis RJ, Lum JJ, Hatzivassiliou G, Thompson CB. The biology of cancer: metabolic programming fuels cell growth and proliferation. Cell Metab (2008) 7:11-20. doi:10.1016/j.cmet.2007.10.002.
14. Deberardinis RJ, Thompson CB. Cellular metabolism and disease: what do metabolic outliers teach us? Cell (2012) 148:1132-44. doi:10.1016/j.cell.2012.02.032.
15. Locasale JW, Cantley LC. Metabolic flux and the regulation of mammalian cell growth. Cell Metab (2011) 14:443-51. doi:10.1016/j.cmet.2011.07.014.
16. Lunt SY, Vander Heiden MG. Aerobic glycolysis: meeting the metabolic requirements of cell proliferation. Annu Rev Cell Dev Biol (2011) 27:441-64. doi:10.1146/annurev-cellbio-092910-154237.
17. Metallo CM, Vander Heiden MG. Understanding metabolic regulation and its influence on cell physiology. Mol Cell (2013) 49:388-98. doi:10.1016/j.molcel.2013.01.018.
18. Ward PS, Thompson CB. Metabolic reprogramming: a cancer hallmark even Warburg did not anticipate. Cancer Cell (2012) 21:297-308. doi:10.1016/j.ccr.2012.02.014.
19. Chatterjee A, Dasgupta SK, Sidransky D. Mitochondrial subversion in cancer. Cancer Prev Res (2011) 4:638-54. doi:10.1158/1940-6207.CAPR-10-0326.
20. Galluzzi L, Morselli E, Kepp O, Vitale I, Rigoni A, Vacchelli E, et al. Mitochondrial gateways to cancer. Mol Aspects Med (2010) 31:1-20. doi:10.1016/j.mam.2009.08.002.
21. Ralph SJ, Rodríguez-Enríquez S, Neuzil J, Saavedra E, Moreno-Sánchez R. The causes of cancer revisited: "mitochondrial malignancy" and ROS-induced oncogenic transformation-why mitochondria are targets for cancer therapy. Mol Aspects Med (2010) 31:145-70. doi:10.1016/j.mam.2010.02.008.
22. Polyak K, Li Y, Zhu H, Lengauer C, Willson JK, Markowitz SD, et al. Somatic mutations of the mitochondrial genome in human colorectal tumours. Nat Genet (1998) 20:291-3. doi:10.1038/3108.
23. Petros JA, Baumann AK, Ruiz-Pesini E, Amin MB, Sun CQ, Hall J, et al. mtDNA mutations increase tumorigenicity in prostate cancer. Proc Natl Acad Sci U S A (2005) 102:719-24. doi:10.1073/pnas.0408894102.
24. Ishikawa K, Takenaga K, Akimoto M, Koshikawa N, Yaaguchi A, Imanishi H, et al. ROS-generating mitochondrial DNA mutations can regulate tumor cell metastasis. Science (2008) 320:661-4. doi:10.1126/science.1156906.
25. Santidrian AF, Matsuno-Yagi A, Ritland M, Seo BB, Leboeuf SE, Gay LJ, et al. Mitochondrial complex I activity and NAD+/NADH balance regulate breast cancer progression. J Clin Invest (2013) 123:1068-81. doi:10.1172/JCI64264.
26. Wallace DC. Mitochondria and cancer. Nat Rev Cancer (2012) 12:685-98. doi:10.1038/nrc3365.
27. Hamanaka RB, Chandel NS. Mitochondrial reactive oxygen species regulate cellular signaling and dictate biological outcomes. Trends Biochem Sci (2010) 35:505-13. doi:10.1016/j.tibs.2010.04.002.
28. Schumacker PT. Reactive oxygen species in cancer cells: live by the sword, die by the sword. Cancer Cell (2006) 10:175-6. doi:10.1016/j.ccr.2006.08.015.
29. Sena LA, Chandel NS. Physiological roles of mitochondrial reactive oxygen species. Mol Cell (2012) 48:158-67. doi:10.1016/j.molcel.2012.09.025.
30. Wheaton WW, Chandel NS. Hypoxia. 2. Hypoxia regulates cellular metabolism. Am J Physiol Cell Physiol (2011) 300:C385-93. doi:10.1152/ajpcell.00485.2010.
31. Raj L, Ide T, Gurkar AU, Foley M, Schenone M, Li X, et al. Selective killing of cancer cells by a small molecule targeting the stress response to ROS. Nature (2011) 475:231-4. doi:10.1038/nature10167.
32. Shaw AT, Winslow MR, Magensantz M, Ouyang C, Dowdle J, Subramanian A, et al. Selective killing of K-ras mutant cancer cells by small molecule inhibitors of oxidative stress. Proc Natl Acad Sci U S A (2011) 108:8773-8. doi:10.1073/pnas.1105941108.
33. Trachootham D, Zhou Y, Zhang H, Demizu Y, Chen ZY, Pelicano H, et al. Selective killing of oncogenically transformed cells through a ROS-mediated mechanism by b-phenylethyl isothiocynate. Cancer Cell (2006) 10:241-52. doi:10.1016/j.ccr.2006.08.009.
34. Liu H, Knabb JR, Spike BT, MacLeod KF. Elevated Parp activity sensitizes Rb deficient cells to DNA damage-induced necrosis. Mol Cancer Res (2009) 7:1099-109. doi:10.1158/1541-7786.MCR-08-0439.
35. Trachootham D, Alexandre J, Huang P. Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach. Nat Rev Drug Discov (2009) 8:579-91. doi:10.1038/nrd2803.
36. Kelly DP, Scarpulla RC. Transcriptional regulatory circuits controlling mitochondrial biogenesis and function. Genes Dev (2004) 18:357-68.
37. Twig G, Hyde B, Shirihai OS. Mitochondrial fusion, fission and autophagy as a quality control axis: the bioenergetic view. Biochim Biophys Acta (2008) 1777:1092-7. doi:10.1016/j.bbabio.2008.05.001.
38. Youle RJ, Narendra DP. Mechanisms of mitophagy. Nat Rev Mol Biol (2011) 12:9-14. doi:10.1038/nrm3028.
39. Detmer SA, Chan DC. Functions and dysfunctions of mitochondrial dynamics. Nat Rev Mol Biol (2007) 8:870-9. doi:10.1038/nrm2275.
40. Suen DF, Norris KL, Youle RJ. Mitochondrial dynamics and apoptosis. Genes Dev (2008) 22:1577-90. doi:10.1101/gad.1658508.
41. Al-Mehdi AB, Pastukh VM, Swiger BM, Reed DJ, Patel MR, Bardwell GC, et al. Perinuclear mitochondrial clustering creates an oxidant-rich nuclear domain required for hypoxia-induced transcription. Sci Signal (2012) 5:ra47. doi:10.1126/scisignal.2002712.
42. Knott AB, Perkins G, Schwarzenbacher R, Bossy-Wetzel E. Mitochondrial fragmentation in neurodegeneration. Nat Rev Neurosci (2008) 9:505-18. doi:10.1038/nrn2417.
43. Twig G, Shirihai OS. The interplay between mitochondrial dynamics and mitophagy. Antioxid Redox Signal (2011) 14:1939-51. doi:10.1089/ars.2010.3779.
44. Autret A, Martin SJ. Emerging role for members of the Bl-2 family in mitochondrial morphogenesis. Mol Cell (2009) 36:355-63. doi:10.1016/j.molcel.2009.10.011.
45. Otera H, Mihara K. Molecular mechanisms and physiologic functions of mitochondrial dynamics. J Biochem (2011) 149:241-51. doi:10.1093/jb/mvr002.
46. Tondera D, Grandemange S, Jourdain A, Karbowski M, Mattenberger Y, Herzig S, et al. SLP-2 is required for stress-induced mitochondrial hyperfusion. EMBO J (2009) 28:1589-600. doi:10.1038/emboj.2009.89.
47. Horn SR, Thomenius MJ, Johnson ES, Freel CD, Wu JQ, Coloff JL, et al. Regulation of mitochondrial morphology by APC/CCdh1-mediated control of Drp1 stability. Mol Biol Cell (2011) 22:1207-16. doi:10.1091/mbc.E10-07-0567.
48. Kashatus DF, Lim KH, Brady DC, Pershing NL, Cox AD, Counter CM. RALA and RALBP1 regulate mitochondrial fission at mitosis. Nat Cell Biol (2011) 13:1108-15. doi:10.1038/ncb2310.
49. Taguchi N, Ishihara N, Jofuku A, Oka T, Mihara K. Mitotic phosphorylation of dynamin-related GTPase Drp1 participates in mitochondrial fission. J Biol Chem (2007) 282:11521-9. doi:10.1074/jbc.M607279200.
50. Youle RJ, Karbowski M. Mitochondrial fission in apoptosis. Nat Rev Mol Biol (2005) 6:657-63. doi:10.1038/nrm1697.
51. Youle RJ, van der Bliek AM. Mitochondrial fission, fusion and stress. Science (2012) 337:1062-5. doi:10.1126/science.1219855.
52. Cereghetti GM, Stangherlin A, de Brito OM, Chang CR, Blackstone C, Bernardi P, et al. Dephosphorylation by calcineurin regulates translocation of Drp1 to mitochondria. Proc Natl Acad Sci U S A (2008) 105:15803-8. doi:10.1073/pnas.0808249105.
53. Chang CR, Blackstone C. Dynamic regulation of mitochondrial fission through modification of the dynamin-related protein Drp1. Ann N Y Acad Sci (2010) 1201:34-9. doi:10.1111/j.1749-6632.2010.05629.x.
54. Wasiak S, Zunino R, McBride HM. Bax/Bak promote sumoylation of DRP1 and its stable association with mitochondria during apoptotic cell death. J Cell Biol (2007) 177:439-50. doi:10.1083/jcb.200610042.
55. Ishihara N, Otera H, Oka T, Mihara K. Regulation and physiologic functions of GTPases in mitochondrial fusion and fission in mammals. Antioxid Redox Signal (2012) 19:389-99. doi:10.1089/ars.2012.4830.
56. Lee YK, Lee HY, Hanna RA, Gustafsson AB. Mitochondrial autophagy by Bnip3 involves Drp1-mediated mitochondrial fission and recruitment of Parkin in cardiac myocytes. Am J Physiol Heart Circ Physiol (2011) 301:H1924-31. doi:10.1152/ajpheart.00368.2011.
57. Losón OC, Song Z, Chen H, Chan DC. Fis1, Mff, MiD49 and MiD51 mediate Drp1 recruitment in mitochondrial fission. Mol Biol Cell (2013) 24:659-67. doi:10.1091/mbc.E12-10-0721.
58. Otera H, Wang C, Cleland MM, Setoguchi K, Yokota S, Youle RJ, et al. Mff is an essential factor for mitochondrial recruitment of Drp1 during mitochondrial fission in mammalian cells. J Cell Biol (2010) 191:1141-58. doi:10.1083/jcb.201007152.
59. Palmer CS, Osellame LD, Laine D, Koutsopoulos OS, Frazier AE, Ryan MT. MiD49 and MiD51, new components of the mitochondrial fission machinery. EMBO Rep (2011) 12:565-73. doi:10.1038/embor.2011.54.
60. Friedman JR, Lackner LL, West M, DiBenedetto JR, Nunnari J, Voeltz GK. ER tubules mark sites of mitochondrial division. Science (2011) 334:358-62. doi:10.1126/science.1207385.
61. de Brito OM, Scorrano L. Mitofusin 2 tethers endoplasmic reticulum to mitochondria. Nature (2008) 456:605-10. doi:10.1038/nature07534.
62. Lackner LL, Ping H, Graef M, Murley A, Nunnari J. Endoplasmic reticulum-associated mitochondria-cortex tether functions in the distribution and inheritance of mitochondria. Proc Natl Acad Sci U S A (2013) 110:E458-67. doi:10.1073/pnas.1215232110.
63. Mitra K, Wunder C, Roysam B, Lin G, Lippincott-Schwartz J. A hyperfused mitochondrial state achieved at G1-S regulates cyclin E buildup and entry into S phase. Proc Natl Acad Sci U S A (2009) 106:11960-5. doi:10.1073/pnas.0904875106.
64. Gomes LC, Di Benedetto G, Scorrano L. During autophagy mitochondria elongate, are spared from degradation and sustain cell viability. Nat Cell Biol (2011) 13:589-98. doi:10.1038/ncb2220.
65. Rambold AS, Kostelecky B, Elia N, Lippincott-Schwartz J. Tubular network formation protects mitochondrial from autophagosomal degradation during nutrient starvation. Proc Natl Acad Sci U S A (2011) 108:10190-5. doi:10.1073/pnas.1107402108.
66. Nagaraj R, Gururaja-Rao S, Jones KT, Slattery M, Negre N, Braas D, et al. Control of mitochondrial structure and function by the Yorkie/YAP oncogenic pathway. Genes Dev (2012) 26:2027-37. doi:10.1101/gad.183061.111.
67. Rossignol R, Gilkerson R, Aggeler R, Yamagata K, Remington SJ, Capaldi RA. Energy substrate modulates mitochondrial structure and oxidative capacity in cancer cells. Cancer Res (2004) 64:985-93. doi:10.1158/0008-5472.CAN-03-1101.
68. Bach D, Pich S, Soriano FX, Vega N, Baumgartner B, Oriola J, et al. Mitofusin-2 determines mitochondrial network architecture and mitochondrial metabolism. A novel regulatory mechanism altered in obesity. J Biol Chem (2003) 278:17190-7. doi:10.1074/jbc.M212754200.
69. Chen H, Chomyn A, Chan DC. Disruption of fusion results in mitochondrial heterogeneity and dysfunction. J Biol Chem (2005) 280:26185-92. doi:10.1074/jbc.M503062200.
70. Lapuente-Brun E, Moreno-Loshuertos R, Acín-Pérez R, Latorre-Pellicer A, Colás C, Balsa E, et al. Supercomplex assembly determines electron flux in the mitochondrial electron transport chain. Science (2013) 340:1567-70. doi:10.1126/science.1230381.
71. Cogliati S, Frezza C, Soriano ME, Varanita T, Quintana-Cabrera R, Corrado M, et al. Mitochondrial cristae shape determines respiratory chain supercomplexes assembly and respiratory efficiency. Cell (2013) 155:160-71. doi:10.1016/j.cell.2013.08.032.
72. Kim H, Scimia MC, Wilkinson D, Trelles RD, Wood MR, Bowtell D, et al. Fine-tuning of Drp1/Fis1 availability by AKAP121/Siah2 regulates mitochondrial adaptation to hypoxia. Mol Cell (2011) 44:532-44. doi:10.1016/j.molcel.2011.08.045.
73. Nakayama K, Frew IJ, Hagensen M, Skals M, Habelhah H, Bhoumik A, et al. Siah2 regulates stability of prolyl-hydroxylases, controls HIF1alpha abundance, and modulates physiological responses to hypoxia. Cell (2004) 117:941-52. doi:10.1016/j.cell.2004.06.001.
74. Rehman J, Zhang HJ, Toth PT, Zhang Y, Marsboom G, Hong Z, et al. Inhibition of mitochondrial fission prevents cell cycle progression in lung cancer. FASEB J (2012) 26:2175-86. doi:10.1096/fj.11-196543.
75. Schieke S, McCoy JP Jr, Finkel T. Coordination of mitochondrial bioenergetics with G1 phase cell cycle progression. Cell Cycle (2008) 7:1782-7. doi:10.4161/cc.7.12.6067.
76. Qian W, Choi SE, Gibson GA, Watkins SC, Bakkenist CJ, Van Houten B. Mitochondrial hyperfusion induced by loss of the fission protein Drp1 causes ATM-dependent G2/M arrest and aneuploidy through DNA replication stress. J Cell Sci (2012) 125:5745-57. doi:10.1242/jcs.109769.
77. Spruck CH, Won KA, Reed SI. Deregulated cyclin E induces chromosome instability. Nature (1999) 401:297-300. doi:10.1038/45836.
78. Havens CG, Ho H, Yoshioka N, Dowdy SF. Regulation of late G1/S phase transition and APCCdh1 by reactive oxygen. Mol Cell Biol (2006) 26:4701-11. doi:10.1128/MCB.00303-06.
79. Almeida A, Bolaños JP, Moncada S. E3 ubiquitin ligase APC/C-Cdh1 accounts for the Warburg effect by linking glycolysis to cell proliferation. Proc Natl Acad Sci U S A (2010) 107:738-41. doi:10.1073/pnas.0913668107.
80. Dang CV. Rethinking the Warburg effect with Myc micromanaging glutamine metabolism. Cancer Res (2010) 70:859-62. doi:10.1158/0008-5472.CAN-09-3556.
81. Dang CV. MYC on the path to cancer. Cell (2012) 149:22-35. doi:10.1016/j.cell.2012.03.003.
82. Nicolay BN, Gameiro PA, Tschöp K, Korenjak M, Heilmann AM, Asara JM, et al. Loss of RBF1 changes glutamine catabolism. Genes Dev (2013) 27:182-96. doi:10.1101/gad.206227.112.
83. Reynolds MR, Lane AN, Robertson B, Kemp S, Liu Y, Hill BG, et al. Control of glutamine metabolism by the tumor suppressor Rb. Oncogene (2013) 1:1-13. doi:10.1038/onc.2012.635.
84. Jahani-Asl A, Cheung EC, Neuspie LM, MacLaurin JG, Fortin A, Park DS, et al. Mitofusin 2 protects cerebellar granule neurons against injury-induced cell death. J Biol Chem (2007) 282:23788-98. doi:10.1074/jbc.M703812200.
85. Frezza C, Cipolat S, Martins de Brito O, Micaroni M, Beznoussenko GV, Rudka T, et al. OPA1 controls apoptotic cristae remodeling independently from mitochondrial fusion. Cell (2006) 126:177-89. doi:10.1016/j.cell.2006.06.025.
86. Yamaguchi R, Lartigue L, Perkins G, Scott RT, Dixit A, Kushnareva Y, et al. Opa1-mediated cristae opening is Bax/Bak and BH3 dependent, required for apoptosis, and independent of Bak oligomerization. Mol Cell (2008) 31:557-69. doi:10.1016/j.molcel.2008.07.010.
87. Arnoult D, Grodet A, Lee YJ, Estaquier J, Blackstone C. Release of OPA1 during apoptosis participates in the rapid and complete release of cytochrome c and subsequent mitochondrial fragmentation. J Biol Chem (2005) 280:35742-50. doi:10.1074/jbc.M505970200.
88. Lee YJ, Jeong SY, Karbowski M, Smith CL, Youle RJ. Roles of the mammalian mitochondrial fission and fusion mediators Fis1, Drp1, and Opa1 in apoptosis. Mol Biol Cell (2004) 15:5001-11. doi:10.1091/mbc.E04-04-0294.
89. Merkwirth C, Dargazanli S, Tatsuta T, Geimer S, Löwer B, Wunderlich FT, et al. Prohibitins control cell proliferation and apoptosis by regulating OPA1-dependent cristae morphogenesis in mitochondria. Genes Dev (2008) 22:476-88. doi:10.1101/gad.460708.
90. Brooks C, Wei Q, Feng L, Dong G, Tao Y, Mei L, et al. Bak regulates mitochondrial morphology and pathology during apoptosis by interacting with mitofusins. Proc Natl Acad Sci U S A (2007) 104:11649-54. doi:10.1073/pnas.0703976104.
91. Montessuit S, Somasekharan SP, Terrones O, Lucken-Ardjomande S, Herzig S, Schwarzenbacher R, et al. Membrane remodeling induced by the dynamin-related protein Drp1 stimulates Bax oligomerization. Cell (2010) 142:889-901. doi:10.1016/j.cell.2010.08.017.
92. Karbowski M, Norris KL, Cleland MM, Jeong SY, Youle RJ. Role of Bax and Bak in mitochondrial morphogenesis. Nature (2006) 443:658-62. doi:10.1038/nature05111.
93. Karbowski M, Youle RJ. Dynamics of mitochondrial morphology in healthy cells and during apoptosis. Cell Death Differ (2003) 10:870-80. doi:10.1038/sj.cdd.4401260.
94. Lindsten T, Ross AJ, King A, Zong WX, Rathmell JC, Shiels HA, et al. The combined functions of proapoptotic Bcl-2 family members Bak and Bax are essential for normal development of multiple tissues. Mol Cell (2000) 6:1389-99. doi:10.1016/S1097-2765(00)00136-2.
95. Wei MC, Zong W, Cheng E, Lindsten T, Panoutsakopoulou V, Ross AJ, et al. Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death. Science (2001) 292:727-30. doi:10.1126/science.1059108.
96. Green DR, Kroemer G. The pathophysiology of mitochondrial cell death. Science (2004) 305:626-9. doi:10.1126/science.1099320.
97. Hoppins S, Edlich F, Cleland MM, Banerjee S, McCaffery JM, Youle RJ, et al. The soluble form of Bax regulates mitochondrial fusion via MFN2 homotypic complexes. Mol Cell (2011) 41:150-60. doi:10.1016/j.molcel.2010.11.030.
98. Li H, Chen Y, Jones AF, Sanger RH, Collis LP, Flannery R, et al. Bcl-xL induces Drp1-dependent synapse formation in cultured hippocampal neurons. Proc Natl Acad Sci U S A (2008) 105:2169-74. doi:10.1073/pnas.0711647105.
99. Perciavalle RM, Stewart DP, Koss B, Lynch J, Milasta S, Bathina M, et al. Anti-apoptotic MCL-1 localizes to the mitochondrial matrix and couples mitochondrial fusion to respiration. Nat Cell Biol (2012) 14:575-83. doi:10.1038/ncb2488.
100. Wang X, Bathina M, Lynch J, Koss B, Calabrese C, Frase S, et al. Deletion of MCL-1 causes lethal cardiac failure and mitochondrial dysfunction. Genes Dev (2013) 27:1351-64. doi:10.1101/gad.215855.113.
101. Thomas RL, Roberts DJ, Kubli DA, Lee YJ, Quinsay MN, Owens JB, et al. Loss of MCL-1 leads to impaired autophagy and rapid development of heart failure. Genes Dev (2013) 27:1365-77. doi:10.1101/gad.215871.113.
102. Kelly PN, Strasser A. The role of Bcl-2 and its pro-survival relatives in tumourigenesis and cancer therapy. Cell Death Differ (2011) 18:1414-24. doi:10.1038/cdd.2011.17.
103. Scarpulla RC, Vega RB, Kelly DP. Transcriptional integration of mitochondrial biogenesis. Trends Endocrinol Metab (2012) 23:459-66. doi:10.1016/j.tem.2012.06.006.
104. Wenz T. Regulation of mitochondrial biogenesis and PGC-1a under cellular stress. Mitochondrion (2013) 13:134-42. doi:10.1016/j.mito.2013.01.006.
105. Chacinska A, Koehler CM, Milenkovic D, Lithgow T, Pfanner N. Importing mitochondrial proteins: machineries and mechanisms. Cell (2009) 138:628-44. doi:10.1016/j.cell.2009.08.005.
106. Dominy JE, Lee YS, Gerhart-Hines Z, Puigserver P. Nutrient-dependent regulation of PGC-1a's acetylation state and metabolic function through the enzymatic activities of Sirt1/GCN5. Biochim Biophys Acta (2010) 1804:1676-83. doi:10.1016/j.bbapap.2009.11.023.
107. Larsson NG, Wang J, Wilhelmsson H, Oldfors A, Rustin P, Lewandoski M, et al. Mitochondrial transcription factor A is necessary for mtDNA maintenance and embryogenesis in mice. Nat Genet (1998) 18:231-6. doi:10.1038/ng0398-231.
108. Kitami T, Logan DJ, Negri J, Hasaka T, Tolliday NJ, Carpenter AE, et al. A chemical screen probing the relationship between mitochondrial content and cell size. PLoS One (2012) 7:e33755. doi:10.1371/journal.pone.0033755.
109. Martínez-Diez M, Santamaría G, Ortega AD, Cuezva JM. Biogenesis and dynamics of mitochondria during the cell cycle: significance of 3'UTRs. PLoS One (2006) 1:e107. doi:10.1371/journal.pone.0000107.
110. Posakony JW, England JM, Attardi G. Mitochondrial growth and division during the cell cycle in HeLa cells. J Cell Biol (1977) 74:468-91. doi:10.1083/jcb.74.2.468.
111. Rasbach KA, Schnellmann RG. Signaling of mitochondrial biogenesis following oxidant injury. J Biol Chem (2007) 282:2355-62. doi:10.1074/jbc.M608009200.
112. Rohas LM, St-Pierre J, Uldry M, Jager S, Handschin C, Spiegelman BM. A fundamental system of cellular energy homeostasis regulated by PGC-1a. Proc Natl Acad Sci U S A (2007) 104:7933-8. doi:10.1073/pnas.0702683104.
113. Canto C, Auwerx J. NAD+ as a signaling molecule modulating metabolism. Cold Spring Harb Symp Quant Biol (2011) 76:291-8. doi:10.1101/sqb.2012.76.010439.
114. Bell EL, Guarente L. The SirT3 divining rod points to oxidative stress. Mol Cell (2011) 42:561-8. doi:10.1016/j.molcel.2011.05.008.
115. Zhang H, Gao P, Fukuda R, Kumar G, Krishnamachary B, Zeller KI, et al. HIF-1 inhibits mitochondrial biogenesis and cellular respiration in VHL-deficient renal cell carcinoma by repression of c-Myc activity. Cancer Cell (2007) 11:407-20. doi:10.1016/j.ccr.2007.04.001.
116. Kim J, Lee JH, Iyer VR. Global identification of MYC target genes reveals its direct role in mitochondrial biogenesis and its E-box usage in vivo. PLoS One (2008) 3:e1798. doi:10.1371/journal.pone.0001798.
117. Li F, Wang Y, Zeller KI, Potter JJ, Wonsey DR, O'Donnell KA, et al. Myc stimulates nuclearly encoded mitochondrial genes and mitochondrial biogenesis. Mol Cell Biol (2007) 25:6225-34. doi:10.1128/MCB.25.14.6225-6234.2005.
118. Finley LW, Carracedo A, Lee JH, Souza AL, Egia A, Zhang J, et al. SIRT3 opposes reprogramming of cancer cell metabolism through HIF1α destabilization. Cancer Cell (2011) 19:416-28. doi:10.1016/j.ccr.2011.02.014.
119. Haq R, Shoag J, Andreu-Perez P, Yokoyama S, Edelman H, Rowe GC, et al. Oncogenic BRAF regulates oxidative metabolism via PGC1a and MITF. Cancer Cell (2013) 23:303-15. doi:10.1016/j.ccr.2013.02.003.
120. Vazquez F, Lim JH, Chim H, Bhalla K, Girnun G, Pierce K, et al. PGC1a expression defines a subset of human melanoma tumors with increased mitochondrial capacity and resistance to oxidative stress. Cancer Cell (2013) 23:287-301. doi:10.1016/j.ccr.2012.11.020.
121. Arany Z, Foo SY, Ma Y, Ruas JL, Bommi-Reddy A, Girnun G, et al. HIF-independent regulation of VEGF and angiogenesis by the transcriptional coactivator PGC-1alpha. Nature (2008) 451:1008-12. doi:10.1038/nature06613.
122. Sahin E, Colla S, Liesa M, Moslehi J, Müller FL, Guo M, et al. Telomere dysfunction induces metabolic and mitochondrial compromise. Nature (2012) 470:359-65. doi:10.1038/nature09787.
123. Lopez-Otin C, Blasco MA, Partridge L, Serrano M, Kroemer G. The hallmarks of aging. Cell (2013) 153:1194-217. doi:10.1016/j.cell.2013.05.039.
124. Sahin E, dePinho RA. Axis of ageing: telomeres, p53 and mitochondria. Nat Rev Cancer (2012) 13:397-404. doi:10.1038/nrm3352.
125. Hu J, Hwang SS, Liesa M, Gan B, Sahin E, Jaskelioff M, et al. Antitelomerase therapy provokes ALT and mitochondrial adaptive mechanisms in cancer. Cell (2012) 148:651-63. doi:10.1016/j.cell.2011.12.028.
126. Glick D, Barth S, MacLeod KF. Autophagy: cellular and molecular mechanisms. J Pathol (2010) 221:3-12. doi:10.1002/path.2697.
127. Kroemer G, Marino G, Levine B. Autophagy and the integrated stress response. Mol Cell (2010) 40:280-93. doi:10.1016/j.molcel.2010.09.023.
128. Levine B, Kroemer G. Autophagy in the pathogenesis of disease. Cell (2008) 132:27-42. doi:10.1016/j.cell.2007.12.018.
129. Mizushima N, Komatsu M. Autophagy: renovation of cells and tissues. Cell (2011) 147:728-41. doi:10.1016/j.cell.2011.10.026.
130. Rabinowitz JD, White E. Autophagy and metabolism. Science (2010) 330:1344-8. doi:10.1126/science.1193497.
131. Twig G, Elorza A, Molina AJ, Mohamed H, Wikstrom JD, Walzer G, et al. Fission and selective fusion govern mitochondrial segregation and elimination by autophagy. EMBO J (2008) 27:433-46. doi:10.1038/sj.emboj.7601963.
132. Graef M, Nunnari J. Mitochondria regulate autophagy by conserved signaling pathways. EMBO J (2011) 30:2101-14. doi:10.1038/emboj.2011.104.
133. Ehses S, Raschke I, Mancuso G, Bernacchia A, Geimer S, Tondera D, et al. Regulation of OPA1 processing and mitochondrial fusion by m-AAA protease isoenzymes and OMA1. J Cell Biol (2009) 187:1023-36. doi:10.1083/jcb.200906084.
134. Head B, Griparic L, Amiri M, Gandre-Babbe S, van der Bliek AM. Inducible proteolytic inactivation of OPA1 mediated by the OMA1 protease in mammalian cells. J Cell Biol (2009) 187:959-66. doi:10.1083/jcb.200906083.
135. Zhang J, Ney PA. Role of BNIP3 and NIX in cell death, autophagy and mitophagy. Cell Death Differ (2009) 16:939-46. doi:10.1038/cdd.2009.16.
136. Narendra D, Walker JE, Youle R. Mitochondrial quality control mediated by PINK1 and Parkin: links to parkinsonism. Cold Spring Harb Perspect Biol (2012) 4:a011338. doi:10.1101/cshperspect.a011338.
137. Narendra DP, Jin SM, Tanaka AJ, Suen DF, Gautier CA, Shen J, et al. PINK1 is selectively stabilized on impaired mitochondria to activate Parkin. PLoS Biol (2010) 8:e1000298. doi:10.1371/journal.pbio.1000298.
138. Chen Y, Dorn GW. PINK1-phosphorylated Mitofusin-2 is a Parkin receptor for culling damaged mitochondria. Science (2013) 340:471-5. doi:10.1126/science.1231031.
139. Narendra D, Tanaka AJ, Suen DF, Youle RJ. Parkin is recruited selectively to impaired mitochondria and promotes their autophagy. J Cell Biol (2008) 83:795-803. doi:10.1083/jcb.200809125.
140. Vives-Bauza C, Zhou C, Huang Y, Cui M, de Vries RL, Kim J, et al. PINK1-dependent recruitment of Parkin to mitochondria in mitophagy. Proc Natl Acad Sci U S A (2010) 107:378-83. doi:10.1073/pnas.0911187107.
141. Chan NC, Salazar AM, Pham AH, Sweredoski MJ, Kolawa NJ, Graham RL, et al. Broad activation of the ubiquitin-proteasome system by Parkin is critical for mitophagy. Hum Mol Genet (2011) 20:1726-37. doi:10.1093/hmg/ddr048.
142. Wang X, Winter D, Ashrafi G, Schlehe J, Wong YL, Selkoe D, et al. PINK1 and Parkin target Miro for phosphorylation and degradation to arrest mitochondrial motility. Cell (2011) 147:893-906. doi:10.1016/j.cell.2011.10.018.
143. Geisler S, Holmström KM, Skujat D, Fiesel FC, Rothfuss OC, Kahle PJ, et al. PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1. Nat Cell Biol (2010) 12:119-31. doi:10.1038/ncb2012.
144. Lee JY, Nagano Y, Taylor JP, Lim KL, Yao TP. Disease-causing mutations in Parkin impair mitochondrial ubiquitination, aggregation, and HDAC6-dependent mitophagy. J Cell Biol (2010) 189:671-9. doi:10.1083/jcb.201001039.
145. Novak I. Mitophagy: a complex mechanism of mitochondrial removal. Antioxid Redox Signal (2012) 17:794-802. doi:10.1089/ars.2011.4407.
146. Narendra D, Kane LA, Hauser DN, Fearnley IM, Youle RJ. p62/SQSTM1 is required for Parkin-induced mitochondrial clustering but not mitophagy; VDAC1 is dispensable for both. Autophagy (2010) 6:1090-106. doi:10.4161/auto.6.8.13426.
147. Houtkooper RH, Mouchiroud L, Ryu D, Moullan N, Katsyuba E, Knott G, et al. Mitonuclear protein imbalance as a conserved longevity mechanism. Nature (2013) 497:451-7. doi:10.1038/nature12188.
148. Durieux J, Wolff S, Dillin A. The cell-non-autonomous nature of electron transport chain-mediated longevity. Cell (2011) 144:79-91. doi:10.1016/j.cell.2010.12.016.
149. Schulz TJ, Zarse K, Voigt A, Urban N, Birringer M, Ristow M. Glucose restriction extends Caenorhabditis elegans life span by inducing mitochondrial respiration and increasing oxidative stress. Cell Metab (2007) 6:280-93. doi:10.1016/j.cmet.2007.08.011.
150. Lee JY, Koga H, Kawaguchi Y, Tang W, Wong E, Gao YS, et al. HDAC6 controls autophagosome maturation essential for ubiquitin-selective quality-control autophagy. EMBO J (2010) 29:969-80. doi:10.1038/emboj.2009.405.
151. Shin JH, Ko HS, Kang HS, Lee YK, Lee YI, Pletinkova O, et al. PARIS (ZNF746) repression of PGC-1α contributes to neurodegeneration in Parkinson's disease. Cell (2011) 144:689-702. doi:10.1016/j.cell.2011.02.010.
152. Cesari R, Martin ES, Calin GA, Pentimalli F, Bichi R, McAdams H, et al. Parkin, a gene implicated in autosomal recessive juvenile parkinsonism, is a candidate tumor suppressor gene on chromosome 6q25-q27. Proc Natl Acad Sci U S A (2003) 100:5956-61. doi:10.1073/pnas.0931262100.
153. Fujiwara M, Marusawa H, Wang HQ, Iwai A, Ikeuchi K, Imai Y, et al. Parkin as a tumor suppressor gene for hepatocellular carcinoma. Oncogene (2008) 27:6002-11. doi:10.1038/onc.2008.199.
154. Kim KY, Stevens MV, Akter MH, Rusk SE, Huang RJ, Cohen A, et al. Parkin is a lipid-responsive regulator of fat uptake in mice and mutant human cells. J Clin Invest (2011) 121:3701-12. doi:10.1172/JCI44736.
155. Zhang C, Lin M, Wu R, Wang X, Yang BG, Levine AJ, et al. Parkin, a p53 target gene, mediates the role of p53 in glucose metabolism and the Warburg effect. Proc Natl Acad Sci U S A (2011) 108:16259-64. doi:10.1073/pnas.1113884108.
156. Guo JY, Chen HY, Mathew R, Fan J, Strohecker AM, Karsli-Uzumbas G, et al. Activated Ras requires autophagy to maintain oxidative metabolism and tumorigenesis. Genes Dev (2011) 25:460-70. doi:10.1101/gad.2016311.
157. Guo JY, Karsli-Uzunbas G, Mathew R, Aisner SC, Kamphorst JJ, Strohecker AM, et al. Autophagy suppresses progression of K-ras-induced lung tumors to oncocytomas and maintains lipid homeostasis. Genes Dev (2013) 27:1447-61. doi:10.1101/gad.219642.113.
158. Chinnadurai G, Vijayalingam S, Gibson SB. BNIP3 subfamily BH3-only proteins: mitochondrial stress sensors in normal and pathological functions. Oncogene (2009) 27:S114-27. doi:10.1038/onc.2009.49.
159. Hardwick JM, Youle RJ. Snapshot: Bcl2 proteins. Cell (2009) 138:404.e1-404.e2. doi:10.1016/j.cell.2009.07.003.
160. Diwan A, Koesters AG, Odley AM, Pushkaran S, Baines CP, Spike BT, et al. Unrestrained erythroblast development in Nix-/- mice reveals a mechanism for apoptotic modulation of erythropoiesis. Proc Natl Acad Sci USA (2007) 104:6794-9. doi:10.1073/pnas.0610666104.
161. Glick D, Zhang W, Beaton M, Marsboom G, Gruber M, Simon MC, et al. BNip3 regulates mitochondrial function and lipid metabolism in the liver. Mol Cell Biol (2012) 32:2570-84. doi:10.1128/MCB.00167-12.
162. Graham RM, Frazier DP, Thompson JW, Haliko S, Li H, Wasserlauf BJ, et al. A unique pathway of cardiac myocyte death caused by hypoxia-acidosis. J Exp Biol (2004) 207:3189-200. doi:10.1242/jeb.01109.
163. Tracy K, MacLeod KF. Regulation of mitochondrial integrity, autophagy and cell survival by BNIP3. Autophagy (2007) 3:616-9.
164. Zhang H, Bosch-Marce M, Shimoda LA, Tan YS, Baek JH, Wesley JB, et al. Mitochondrial autophagy is a HIF-1 dependent adaptive metabolic response to hypoxia. J Biol Chem (2008) 283:10892-903. doi:10.1074/jbc.M800102200.
165. Hanna RA, Quinsay MN, Orogo AM, Giang K, Rikka S, Gustafsson AB. Microtubule-associated protein 1 light chain 3 (LC3) interacts with BNip3 protein to selectively remove endoplasmic reticulum and mitochondria via autophagy. J Biol Chem (2012) 287:19094-104. doi:10.1074/jbc.M111.322933.
166. Schwarten M, Mohrluder J, Ma P, Stoldt M, Thielman Y, Stangler T, et al. Nix binds to GABARAP: a possible crosstalk between apoptosis and autophagy. Autophagy (2009) 5:690-8. doi:10.4161/auto.5.5.8494.
167. Kanki T, Wang KKW, Caio Y, Baba M, Klionsky DJ. Atg32 is a mitochondrial protein that confers selectivity during mitophagy. Dev Cell (2009) 17:98-109. doi:10.1016/j.devcel.2009.06.014.
168. Okamoto K, Kondo-Okamoto N, Ohsumi Y. Mitochondrial-anchored receptor Atg32 mediates degradation of mitochondria via selective autophagy. Dev Cell (2009) 17:87-97. doi:10.1016/j.devcel.2009.06.013.
169. Sandoval H, Thiagarajan P, Dasgupta SK, Scumacker A, Prchal JT, Chen M, et al. Essential role for Nix in autophagic maturation of red cells. Nature (2008) 454:232-5. doi:10.1038/nature07006.
170. Schweers RL, Zhang J, Randall MS, Loyd MR, Li W, Dorsey FC, et al. NIX is required for programmed mitochondrial clearance during reticulocyte maturation. Proc Natl Acad Sci USA (2007) 104:19500-5. doi:10.1073/pnas.0708818104.
171. Mammucari C, Milan G, Romanello V, Masiero E, Rudolf R, Del Piccolo P, et al. FoxO3 controls autophagy in skeletal muscle in vivo. Cell Metab (2007) 6:458-71. doi:10.1016/j.cmet.2007.11.001.
172. Ray R, Chen G, Vande Velde C, Cizeau J, Park JH, Reed JC, et al. BNIP3 heterodimerizes with Bcl-2/Bcl-XL and induces cell death independent of a Bcl-2 homology 3 (BH3) domain at both mitochondrial and nonmitochondrial sites. J Biol Chem (2000) 275:1439-48. doi:10.1074/jbc.275.2.1439.
173. Tracy K, Dibling BC, Spike BT, Knabb JR, Schumacker P, MacLeod KF. BNIP3 is a RB/E2F target gene required for hypoxia-induced autophagy. Mol Cell Biol (2007) 27:6229-42. doi:10.1128/MCB.02246-06.
174. Chaanine AH, Gordon RE, Kohlbrenner E, Benard L, Jeong D, Hajjar RJ. Potential role of BNIP3 in cardiac re-modeling, myocardial stiffness and endoplasmic-reticulum-mitochondrial calcium homeostasis in diastolic and systolic heart failure. Circ Heart Fail (2013) 6:572-83. doi:10.1161/CIRCHEARTFAILURE.112.000200.
175. Landes T, Emorine LJ, Courilleau D, Rojo M, Belenguer P, Arnaune-Pelloquin L. The BH3-only BNip3 binds to the dynamin Opa1 to promote mitochondrial fragmentation and apoptosis by distinct mechanisms. EMBO Rep (2010) 11:459-65. doi:10.1038/embor.2010.50.
176. Quinsay MN, Lee YS, Rikka S, Sayen MR, Molkentin JD, Gottlieb RA, et al. BNip3 mediates permeabilization of mitochondria and release of cytochrome c via a novel mechanism. J Mol Cell Cardiol (2009) 48:1146-56. doi:10.1016/j.yjmcc.2009.12.004.
177. Ding WX, Ni HM, Li M, Liao Y, Chen X, Stolz DB, et al. Nix is critical to two distinct phases of mitophagy, reactive oxygen species-mediated autophagy induction and Parkin-ubiquitin-p62-mediated mitochondrial priming. J Biol Chem (2010) 285:27879-90. doi:10.1074/jbc.M110.119537.
178. Li Y, Wang Y, Kim E, Beemiller P, Wang CY, Swanson J, et al. Bnip3 mediates the hypoxia-induced inhibition on mTOR by interacting with Rheb. J Biol Chem (2007) 282:35803-13. doi:10.1074/jbc.M705231200.
179. Melser S, Chatelain EH, Lavie J, Mahfouf W, Jose C, Obre E, et al. Rheb regulates mitophagy induced by mitochondrial energetic status. Cell Metab (2013) 17:719-30. doi:10.1016/j.cmet.2013.03.014.
180. Bruick RK. Expression of the gene encoding the proapoptotic Nip3 protein is induced by hypoxia. Proc Natl Acad Sci U S A (2000) 97:9082-7. doi:10.1073/pnas.97.16.9082.
181. Guo K, Searfoss G, Krolikowski D, Pagnoni M, Franks C, Clark K, et al. Hypoxia induces the expression of the pro-apoptotic gene BNIP3. Cell Death Differ (2001) 8:367-76. doi:10.1038/sj.cdd.4400810.
182. Dayan F, Roux D, Brahimi-Horn C, Pouyssegur J, Mazure NM. The oxygen sensing factor-inhibiting hypoxia-inducible factor-1 controls expression of distinct genes through the bi-functional transcriptional character of hypoxia-inducible factor-1a. Cancer Res (2006) 66:3688-98. doi:10.1158/0008-5472.CAN-05-4564.
183. Kasper LH, Boussouar F, Boyd K, Xu W, Biesen M, Rehg J, et al. Two transcriptional mechanisms cooperate for the bulk of HIF-1-responsive gene expression. EMBO J (2005) 24:3846-58. doi:10.1038/sj.emboj.7600846.
184. Pouyssegur J, Dayan F, Mazure NM. Hypoxia signalling in cancer and approaches to enforce tumour regression. Nature (2006) 441:437-43. doi:10.1038/nature04871.
185. Shaw J, Yurkova N, Zhang T, Gang H, Aguilar F, Weidman D, et al. Antagonism of E2F-1 regulated Bnip3 transcription by NF-kappaB is essential for basal cell survival. Proc Natl Acad Sci U S A (2008) 105:20734-9. doi:10.1073/pnas.0807735105.
186. Kalas W, Swiderek E, Rapak A, Kopij M, Rak JW, Strzadala L. H-ras up-regulates expression of BNIP3. Anticancer Res (2011) 31:2869-75.
187. Wu SY, Lan SH, Cheng DE, Chen WK, Shen CH, Lee YR, et al. Ras-related tumorigenesis is suppressed by BNIP3-mediated autophagy through inhibition of cell proliferation. Neoplasia (2011) 13:1171-82.
188. Feng X, Liu X, Zhang W, Xiao W. p53 directly suppresses BNIP3 expression to protect against hypoxia-induced cell death. EMBO J (2011) 30:3397-415. doi:10.1038/emboj.2011.248.
189. Fei P, Wang W, Kim SH, Wang S, Burns TF, Sax JK, et al. Bnip3L is induced by p53 under hypoxia, and its knockdown promotes tumor growth. Cancer Cell (2005) 6:597-609. doi:10.1016/j.ccr.2004.10.012.
190. Koop EA, van Laar T, van Wichen DF, de Weger RA, van der Wall E, van Diest PJ. Expression of BNIP3 in invasive breast cancer: correlations with the hypoxic response and clinicopathological features. BMC Cancer (2009) 9:175. doi:10.1186/1471-2407-9-175.
191. Okami J, Simeone DM, Logsdon CD. Silencing of the hypoxia-inducible cell death protein BNIP3 in pancreatic cancer. Cancer Res (2004) 64:5338-46. doi:10.1158/0008-5472.CAN-04-0089.
192. Sowter HM, Ferguson M, Pym C, Watson P, Fox SB, Han C, et al. Expression of the cell death genes BNip3 and Nix in ductal carcinoma in situ of the breast; correlation of BNip3 levels with necrosis and grade. J Path (2003) 201:573-80. doi:10.1002/path.1486.
193. Tan EY, Campo L, Han C, Turley H, Pezzella F, Gatter KC, et al. BNIP3 as a progression marker in primary human breast cancer; opposing functions in in situ versus invasive cancer. Clin Cancer Res (2007) 13:467-74. doi:10.1158/1078-0432.CCR-06-1466.
194. Abe T, Toyota M, Suzuki H, Murai M, Akino K, Ueno M, et al. Upregulation of BNIP3 by 5-aza-2'-deoxycytidine sensitizes pancreatic cancer cells to hypoxia-mediated cell death. J Gastroenterol (2005) 40:504-10. doi:10.1007/s00535-005-1576-1.
195. Bacon AL, Fox SB, Turley H, Harris AL. Selective silencing of the hypoxia-inducible factor 1 target gene BNIP3 by histone deacetylation and methylation in colorectal cancer. Oncogene (2006) 26:132-41. doi:10.1038/sj.onc.1209761.
196. Calvisi DF, Ladu S, Gorden A, Farina M, Lee JS, Conner E, et al. Mechanistic and prognostic significance of aberrant methylation in the molecular pathogenesis of human hepatocellular carcinoma. J Clin Invest (2007) 117:2713-22. doi:10.1172/JCI31457.
197. Castro M, Grau L, Puerta P, Gimenez L, Venditti J, Quadrelli S, et al. Multiplexed methylation profiles of tumor suppressor genes and clinical outcome in lung cancer. J Transl Med (2010) 8:1-11. doi:10.1186/1479-5876-8-86.
198. Erkan M, Kleef J, Esposito I, Giese T, Ketterer K, Buchler MW, et al. Loss of BNIP3 expression is a late event in pancreatic cancer contributing to chemoresistance and worsened prognosis. Oncogene (2005) 24:4421-32. doi:10.1038/sj.onc.1208642.
199. Murai M, Toyota M, Satoh A, Suzuki H, Akino K, Mita H, et al. Aberrant methylation associated with silencing BNIP3 expression in haematopoietic tumours. Br J Cancer (2005) 92:1165-72. doi:10.1038/sj.bjc.6602422.
200. Murai M, Toyota M, Suzuki H, Satoh A, Sasaki Y, Akino K, et al. Aberrant methylation and silencing of the BNIP3 gene in colorectal and gastric cancer. Clin Cancer Res (2005) 11:1021-7.
201. Beroukhim R, Mermel CH, Porter D, Wei G, Raychaudhuri S, Donovan J, et al. The landscape of somatic copy-number alteration across human cancers. Nature (2010) 463:899-905. doi:10.1038/nature08822.
202. Chen X, Gong J, Zeng H, Chen N, Huang R, Huang Y, et al. MicroRNA145 targets BNIP3 and suppresses prostate cancer progression. Cancer Res (2010) 70:2728-38. doi:10.1158/0008-5472.CAN-09-3718.
203. Manka D, Spicer Z, Millhorn DE. Bcl-2/Adenovirus E1B 19 kDa interacting protein-3 knockdown enables growth of breast cancer metastases in the lung, liver and bone. Cancer Res (2005) 65:11689-93. doi:10.1158/0008-5472.CAN-05-3091.
204. Hailey DW, Rambold AS, Satpute-Krishnan P, Mitra K, Sougrat R, Kim PK, et al. Mitochondria supply membranes for autophagosome biogenesis during starvation. Cell (2010) 141:656-67. doi:10.1016/j.cell.2010.04.009.
205. Hamasaki M, Furuta N, Matsuda A, Nezu A, Yamamoto A, Fujita N, et al. Autophagosomes form at ER-mitochondria contact sites. Nature (2013) 495:389-93. doi:10.1038/nature11910.
206. Diwan A, Matkovich SJ, Yuan Q, Zhao W, Yatani A, Brown JH, et al. Endoplasmic reticulum-mitochondria crosstalk in NIX-mediated murine cell death. J Clin Invest (2009) 119:203-12. doi:10.1172/JCI36445.
207. Boya P, González-Polo RA, Casares N, Perfettini JL, Dessen P, Larochette N, et al. Inhibition of macroautophagy triggers apoptosis. Mol Cell Biol (2005) 25:1025-40. doi:10.1128/MCB.25.3.1025-1040.2005.
208. Pattingre S, Tassa A, Qu X, Garuti R, Linag XH, Mizushima N, et al. Bcl-2 anti-apoptotic proteins inhibit Beclin 1-dependent autophagy. Cell (2005) 122:927-39. doi:10.1016/j.cell.2005.07.002.
209. Wei G, Pattingre S, Sinha S, Bassik MC, Levine B. JNK1-mediated phosphorylation of Bcl-2 regulates starvation-induced autophagy. Mol Cell (2008) 30:678-88. doi:10.1016/j.molcel.2008.06.001.
210. Rubinstein AD, Eisenstein M, Ber Y, Bialik S, Kimchi A. The autophagy protein Atg12 associates with antiapoptotic Bcl-2 family members to promote mitochondrial apoptosis. Mol Cell (2011) 44:698-709. doi:10.1016/j.molcel.2011.10.014.
211. Yousefi S, Perozzo R, Schmid I, Zieiecki A, Schaffner T, Scapozza L, et al. Calpain-mediated cleavage of Atg5 switches autophagy to apoptosis. Nat Cell Biol (2006) 8:1124-32. doi:10.1038/ncb1482.
212. Lee IH, Kawai Y, Fergusson MM, Rovira II, Bishop AJ, Motoyama N, et al. Atg7 modulates p53 activity to regulate cell cycle and survival during metabolic stress. Science (2012) 336:225-8. doi:10.1126/science.1218395.
213. Tang D, Kang R, Livesey KM, Cheh CW, Farkas A, Loughran P, et al. Endogenous HMGB1 regulates autophagy. J Cell Biol (2010) 190:881-92. doi:10.1083/jcb.200911078.
214. Russo R, Berliocchi L, Adornetto A, Varano GP, Cavaliere F, Nucci C, et al. Calpain-mediated cleavage of Beclin-1 and autophagy deregulation following retinal ischemic injury in vivo. Cell Death Dis (2011) 2:e144. doi:10.1038/cddis.2011.29.
215. Betin VM, Lane JD. Caspase cleavage of Atg4D stimulates GABARAP-L1 processing and triggers mitochondrial targeting and apoptosis. J Cell Sci (2009) 122:2554-66. doi:10.1242/jcs.046250.
216. Wirawan E, Vande Walle L, Kersse K, Cornelis S, Claerhout S, Vanoverberghe I, et al. Caspase-mediated cleavage of Beclin-1 inactivates Beclin-1-induced autophagy and enhances apoptosis by promoting the release of proapoptotic factors from mitochondria. Cell Death Dis (2010) 1:e18. doi:10.1038/cddis.2009.16.
217. Diwan A, Krenz M, Syed FM, Wansapura J, Ren X, Koesters AG, et al. Inhibition of ischemic cardiomyocyte apoptosis through targeted ablation of BNip3 restrains postinfarction remodeling in mice. J Clin Invest (2007) 117:2825-33. doi:10.1172/JCI32490.
218. Liu L, Feng D, Chen G, Chen M, Zheng Q, Song P, et al. Mitochondrial outer-membrane protein FUNDC1 mediates hypoxia-induced mitophagy in mammalian cells. Nat Cell Biol (2012) 14:177-85. doi:10.1038/ncb2422.
219. Kujoth GC, Hiona A, Pugh TD, Someya S, Panzer K, Wohlgemuth SE, et al. Mitochondrial DNA mutations, oxidative stress, and apoptosis in mammalian aging. Science (2005) 309:481-4. doi:10.1126/science.1112125.
220. Trifunovic A, Wredenberg A, Falkenberg M, Spelbrink JN, Rovio AT, Bruder CE, et al. Premature ageing in mice expressing defective mitochondrial DNA polymerase. Nature (2004) 429:417-23. doi:10.1038/nature02517.
221. Vermulst M, Wanagat J, Kujoth GC, Bielas JH, Rabinovitch PS, Prolla TA, et al. DNA deletions and clonal mutations drive premature aging in mitochondrial mutator mice. Nat Genet (2008) 40:392-4. doi:10.1038/ng.95.
222. Ahlqvist KJ, Hämäläinen RH, Yatsuga S, Uutela M, Terzioglu M, Götz A, et al. Somatic progenitor cell vulnerability to mitochondrial DNA mutagenesis underlies progeroid phenotypes in Polg mutator mice. Cell Metab (2012) 15:100-9. doi:10.1016/j.cmet.2011.11.012.
223. Lee HY, Choi CS, Birkenfeld AL, Alves TC, Jornayvaz FR, Jurczak MJ, et al. Targeted expression of catalase to mitochondria prevents age-associated reductions in mitochondrial function and insulin resistance. Cell Metab (2010) 12:668-74. doi:10.1016/j.cmet.2010.11.004.
224. Schriner SE, Linford NJ, Martin GM, Treuting P, Ogburn CE, Emond M, et al. Extension of murine life span by overexpression of catalase targeted to mitochondria. Science (2005) 308:1909-11. doi:10.1126/science.1106653.
225. Veatch JR, McMurray MA, Nelson ZW, Gottschling DE. Mitochondrial dysfunction leads to nuclear genome instability via an iron-sulfur cluster defect. Cell (2009) 137:1247-58. doi:10.1016/j.cell.2009.04.014.
226. Kaelin WGJ, McKnight SL. Influence of metabolism on epigenetics and disease. Cell (2013) 153:56-69. doi:10.1016/j.cell.2013.03.004.
227. Lu C, Thompson CB. Metabolic regulation of epigenetics. Cell Metab (2012) 16:9-17. doi:10.1016/j.cmet.2012.06.001.
228. Wellen KE, Hatzivassiliou G, Sachdeva UM, Bui TV, Cross JR, Thompson CB. ATP-citrate lyase links cellular metabolism to histone acetylation. Science (2009) 324:1076-80. doi:10.1126/science.1164097.
229. Losman JA, Kaelin WGJ. What a difference a hydroxyl makes: mutant IDH, (R)-2-hydroxyglutarate, and cancer. Genes Dev (2013) 27:836-52. doi:10.1101/gad.217406.113.
230. Mardis ER, Ding L, Dooling DJ, Larson DE, McLellan MD, Chen K, et al. Recurring mutations found by sequencing an acute myeloid leukemia genome. N Engl J Med (2009) 361:1058-66. doi:10.1056/NEJMoa0903840.
231. Ward PS, Patel J, Wise DR, Abdel-Wahab O, Bennett BD, Coller HA, et al. The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate. Cancer Cell (2010) 17:225-34. doi:10.1016/j.ccr.2010.01.020.
232. Yan H, Parsons DW, Jin G, McLendon R, Rasheed BA, Yuan W, et al. IDH1 and IDH2 mutations in gliomas. N Engl J Med (2009) 360:765-73. doi:10.1056/NEJMoa0808710.
233. Sciacovelli M, Guzzo G, Morello V, Frezza C, Zheng L, Nannini N, et al. The mitochondrial chaperone TRAP1 promotes neoplastic growth by inhibiting succinate dehydrogenase. Cell Metab (2013) 17:988-99. doi:10.1016/j.cmet.2013.04.019.
234. Koivunen P, Hirsilä M, Remes AM, Hassinen IE, Kivirikko KI, Myllyharju J. Inhibition of hypoxia-inducible factor (HIF) hydroxylases by citric acid cycle intermediates: possible links between cell metabolism and stabilization of HIF. J Biol Chem (2007) 282:4524-32. doi:10.1074/jbc.M610415200.
235. Selak MA, Armour SM, MacKenzie ED, Boulahbel H, Watson DG, Mansfield KD, et al. Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase. Cancer Cell (2005) 7:77-85. doi:10.1016/j.ccr.2004.11.022.
236. Xiao M, Yang H, Xu W, Ma S, Lin H, Zhu H, et al. Inhibition of α-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors. Genes Dev (2012) 26:1326-38. doi:10.1101/gad.191056.112.
237. Xu W, Yang H, Liu Y, Yang Y, Wang P, Kim SH, et al. Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of α-ketoglutarate-dependent dioxygenases. Cancer Cell (2011) 19:17-30. doi:10.1016/j.ccr.2010.12.014.
238. Zhao S, Lin Y, Xu W, Jiang W, Zha Z, Wang P, et al. Glioma-derived mutations in IDH1 dominantly inhibit IDH1 catalytic activity and induce HIF-1alpha. Science (2009) 324:261-5. doi:10.1126/science.1170944.
239. Sasaki M, Knobbe CB, Itsumi M, Elia AJ, Harris IS, Chio II, et al. D-2-hydroxyglutarate produced by mutant IDH1 perturbs collagen maturation and basement membrane function. Genes Dev (2012) 26:2038-49. doi:10.1101/gad.198200.112.
240. Figueroa ME, Abdel-Wahab O, Lu C, Ward PS, Patel J, Shih A, et al. Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation. Cancer Cell (2010) 18:553-67. doi:10.1016/j.ccr.2010.11.015.
241. Turcan S, Rohle D, Goenka A, Walsh LA, Fang F, Yilmaz E, et al. IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype. Nature (2012) 483:479-83. doi:10.1038/nature10866.
242. Sasaki M, Knobbe CB, Munger JC, Lind EF, Brenner D, Brüstle A, et al. IDH1(R132H) mutation increases murine haematopoietic progenitors and alters epigenetics. Nature (2012) 488:656-9. doi:10.1038/nature11323.
243. Lu C, Ward PS, Kapoor GS, Rohle D, Turcan S, Abdel-Wahab O, et al. IDH mutation impairs histone demethylation and results in a block to cell differentiation. Nature (2012) 483:474-8. doi:10.1038/nature10860.
244. Losman JA, Looper RE, Koivunen P, Lee SH, Schneider RK, McMahon C, et al. (R)-2-hydroxyglutarate is sufficient to promote leukemogenesis and its effects are reversible. Science (2013) 339:1621-5. doi:10.1126/science.1231677.
245. Sullivan LB, Garcia-Martinez E, Nguyen H, Mullen AR, Dufour E, Sudarshan S, et al. The Proto-oncometabolite fumarate binds glutathione to amplify ROS-dependent signaling. Mol Cell (2013) 51:236-48. doi:10.1016/j.molcel.2013.05.003.
246. Adam J, Hatipoglu E, O'Flaherty L, Ternette N, Sahgal N, Lockstone H, et al. Renal cyst formation in Fh1-deficient mice is independent of the Hif/Phd pathway: roles for fumarate in KEAP1 succination and Nrf2 signaling. Cancer Cell (2011) 20:524-37. doi:10.1016/j.ccr.2011.09.006.
247. Ooi A, Wong JC, Petillo D, Roossien D, Perrier-Trudova V, Whitten D, et al. An antioxidant response phenotype shared between hereditary and sporadic type 2 papillary renal cell carcinoma. Cancer Cell (2011) 20:511-23. doi:10.1016/j.ccr.2011.08.024.
248. Ternette N, Yang M, Laroyia M, Kitagawa M, O'Flaherty L, Wolhulter K, et al. Inhibition of mitochondrial aconitase by succination in fumarate hydratase deficiency. Cell Rep (2013) 3:689-700. doi:10.1016/j.celrep.2013.02.013.
249. Metallo CM, Gameiro PA, Bell EL, Mattaini KR, Yang J, Hiller K, et al. Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia. Nature (2011) 481:380-4. doi:10.1038/nature10602.
250. Mullen AR, Wheaton WW, Jin ES, Chen PH, Sullivan LB, Cheng T, et al. Reductive carboxylation supports growth in tumour cells with defective mitochondria. Nature (2011) 481:385-8. doi:10.1038/nature10642.
251. Frezza C, Zheng L, Folger O, Rajagopalan KN, MacKenzie ED, Jerby L, et al. Haem oxygenase is synthetically lethal with the tumour suppressor fumarate hydratase. Nature (2011) 477:225-8. doi:10.1038/nature10363.
252. Tan M, Luo H, Lee S, Jin F, Yang JS, Montellier E, et al. Identification of 67 histone marks and histone lysine crotonylation as a new type of histone modification. Cell (2011) 146:1016-28. doi:10.1016/j.cell.2011.08.008.
253. Rizzuto R, De Stefani D, Raffaello A, Mammucari C. Mitochondria as sensors and regulators of calcium signaling. Nat Rev Mol Cell Biol (2012) 13:566-78. doi:10.1038/nrm3412.
254. Rowland AA, Voeltz GK. Endoplasmic reticulum mitochondria contacts: function of the junction. Nat Rev Mol Cell Biol (2012) 13:607-15. doi:10.1038/nrm3440.
255. Szabadkai G, Bianchi K, Várnai P, De Stefani D, Wieckowski MR, Cavagna D, et al. Chaperone-mediated coupling of endoplasmic reticulum and mitochondrial Ca2+ channels. J Cell Biol (2006) 175:901-11. doi:10.1083/jcb.200608073.
256. Rapizzi E, Pinton P, Szabadkai G, Wieckowski MR, Vandecasteele G, Baird G, et al. Recombinant expression of the voltage-dependent anion channel enhances the transfer of Ca2+ microdomains to mitochondria. J Cell Biol (2002) 159:613-24. doi:10.1083/jcb.200205091.
257. White C, Li CY, Yang J, Petrenko NB, Madesh M, Thompson CB, et al. The endoplasmic reticulum gateway to apoptosis by Bcl-XL modulation of the InsP3R. Nat Cell Biol (2005) 7:1021-8. doi:10.1038/ncb1302.
258. McCormack JG, Halestrap AP, Denton RM. Role of calcium ions in regulation of mammalian intramitochondrial metabolism. Physiol Rev (1990) 70:391-425.
259. Saotome M, Safiulina D, Szabadkai G, Das S, Fransson A, Aspenstrom P, et al. Bidirectional Ca2+-dependent control of mitochondrial dynamics by the Miro GTPase. Proc Natl Acad Sci U S A (2008) 105:20728-33. doi:10.1073/pnas.0808953105.
260. Storr SJ, Carragher NO, Frame MC, Parr T, Martin SG. The calpain system and cancer. Nat Rev Cancer (2011) 11:364-74. doi:10.1038/nrc3050.
261. Racioppi L, Means AR. Calcium/calmodulin-dependent protein kinase kinase 2: roles in signaling and pathophysiology. J Biol Chem (2012) 287:31658-65. doi:10.1074/jbc.R112.356485.
262. Prevarskaya N, Skryma R, Shuba Y. Calcium in tumour metastasis: new roles for known actors. Nat Rev Cancer (2011) 11:609-18. doi:10.1038/nrc3105.
263. Amuthan G, Biswas G, Zhang SY, Klein-Szanto A, Vijayasarathy C, Avadhani NG. Mitochondria-to-nucleus stress signaling induces phenotypic changes, tumor progression and cell invasion. EMBO J (2001) 20:1910-20. doi:10.1093/emboj/20.8.1910.
264. Amuthan G, Biswas G, Ananadatheerthavarada HK, Vijayasarathy C, Shephard HM, Avadhani NG. Mitochondrial stress-induced calcium signaling, phenotypic changes and invasive behavior in human lung carcinoma A549 cells. Oncogene (2002) 21:7839-49. doi:10.1038/sj.onc.1205983.
265. Biswas G, Anandatheerthavarada HK, Zaidi M, Avadhani NG. Mitochondria to nucleus stress signaling: a distinctive mechanism of NFkappaB/Rel activation through calcineurin-mediated inactivation of IkappaBbeta. J Cell Biol (2003) 161:507-19. doi:10.1083/jcb.200211104.
266. Biswas G, Tang W, Sondheimer N, Guha M, Bansal S, Avadhani NG. A distinctive physiological role for IkappaBbeta in the propagation of mitochondrial respiratory stress signaling. J Biol Chem (2008) 283:12586-94. doi:10.1074/jbc.M710481200.
267. Karin M, Greten FR. NF-kB: linking inflammation and immunity to cancer development and progression. Nat Rev Immunol (2005) 5:749-59. doi:10.1038/nri1703.
268. Oeckinghaus A, Ghosh S. The NF-kappaB family of transcription factors and its regulation. Cold Spring Harb Perspect Biol (2009) 1:1-14. doi:10.1101/cshperspect.a000034.
269. Rius J, Guma M, Schachtrup C, Akassoglou K, Zinkernagel AS, Nizet V, et al. NF-kB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1a. Nature (2008) 453:807-11. doi:10.1038/nature06905.
270. Balaban RS, Nemoto S, Finkel T. Mitochondria, oxidants and aging. Cell (2005) 120:483-95. doi:10.1016/j.cell.2005.02.001.
271. Tormos KV, Anso E, Hamanaka RB, Eisenbart J, Joseph J, Kalyanaraman B, et al. Mitochondrial complex III ROS regulate adipocyte differentiation. Cell Metab (2011) 14:537-44. doi:10.1016/j.cmet.2011.08.007.
272. Weinberg F, Hamanaka RB, Wheaton WW, Weinberg S, Joseph JW, Lopez M, et al. Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity. Proc Natl Acad Sci U S A (2010) 107:8788-93. doi:10.1073/pnas.1003428107.
273. Gao P, Zhang H, Dinavahi R, Li F, Xiang Y, Raman V, et al. HIF-dependent antitumorigenic effect of antioxidants in vivo. Cancer Cell (2007) 12:230-8. doi:10.1016/j.ccr.2007.08.004.
274. Ma Q, Cavallin LE, Yan B, Zhu S, Duran EM, Wang H, et al. Antitumorigenesis of antioxidants in a transgenic Rac1 model of Kaposi's sarcoma. Proc Natl Acad Sci U S A (2009) 106:8683-8. doi:10.1073/pnas.0812688106.
275. Tonks NK. Redox redux: revisiting PTPs and the control of cell signaling. Cell (2005) 121:667-70. doi:10.1016/j.cell.2005.05.016.
276. Hampton MB, Fadeel B, Orrenius S. Redox regulation of the caspases during apoptosis. Ann N Y Acad Sci (1998) 854:328-35. doi:10.1111/j.1749-6632.1998.tb09913.x.
277. Lee SR, Yang KS, Kwon J, Lee C, Jeong W, Rhee SG. Reversible inactivation of the tumor suppressor PTEN by H2O2. J Biol Chem (2002) 277:20336-42. doi:10.1074/jbc.M111899200.
278. Buhrman G, Parker B, Sohn J, Rudolph J, Mattos C. Structural mechanism of oxidative regulation of the phosphatase Cdc25B via an intramolecular disulfide bond. Biochemistry (2005) 44:5307-16. doi:10.1021/bi058011y.
279. Kamata H, Honda S, Maeda S, Chang L, Hirata H, Karin M. Reactive oxygen species promote TNFalpha-induced death and sustained JNK activation by inhibiting MAP kinase phosphatases. Cell (2005) 120:649-61. doi:10.1016/j.cell.2004.12.041.
280. Brunelle JK, Bell EL, Quesada NM, Vercauteren K, Tiranti V, Zeviani M, et al. Oxygen sensing requires mitochondrial ROS but not oxidative phosphorylation. Cell Metab (2005) 1:409-14. doi:10.1016/j.cmet.2005.05.002.
281. Chandel NS, McClintock DS, Feliciano CE, Wood TM, Melendez JA, Rodriguez AM, et al. Reactive oxygen species generated at mitochondrial complex III stabilize hypoxia-inducible factor-1alpha during hypoxia: a mechanism of O2 sensing. J Biol Chem (2000) 275:25130-8. doi:10.1074/jbc.M001914200.
282. Guzy RD, Hoyos B, Robin E, Chen H, Liu L, Mansfield KD, et al. Mitochondrial complex III is required for hypoxia-induced ROS production and cellular oxygen sensing. Cell Metab (2005) 1:401-8. doi:10.1016/j.cmet.2005.05.001.
283. Guzy RD, Schumacker PT. Oxygen sensing by mitochondria at Complex III: the paradox of increased reactive oxygen species during hypoxia. Exp Physiol (2006) 91:807-19.
284. Mansfield KD, Guzy RD, Pan Y, Young RM, Cash TP, Schumacker PT, et al. Mitochondrial dysfunction resulting from loss of cytochrome c impairs cellular oxygen sensing and hypoxic HIF-alpha activation. Cell Metab (2005) 1:393-9. doi:10.1016/j.cmet.2005.05.003.
285. Kim JW, Tchernyshyov I, Semenza GL, Dang CV. HIF-1 mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia. Cell Metab (2006) 3:177-85. doi:10.1016/j.cmet.2006.02.002.
286. Papandreou I, Cairns RA, Fontana L, Lim AL, Denko NC. HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption. Cell Metab (2006) 3:187-97. doi:10.1016/j.cmet.2006.01.012.
287. Fukuda R, Zhang H, Kim J, Shimoda LA, Dang CV, Semenza GL. HIF-1 regulates cytochrome oxidase subunits to optimize efficiency of respiration in hypoxic cells. Cell (2007) 129:111-22. doi:10.1016/j.cell.2007.01.047.
288. Tello D, Balsa E, Acosta-Iborra B, Fuertes-Yebra E, Elorza A, Ordóñez á, et al. Induction of the mitochondrial NDUFA4L2 protein by HIF-1α decreases oxygen consumption by inhibiting Complex I activity. Cell Metab (2011) 14:768-79. doi:10.1016/j.cmet.2011.10.008.
289. Choksi S, Lin YS, Pobezinskaya Y, Chen L, Park C, Morgan M, et al. A HIF-1 target, ATIA, protects cells from apoptosis by modulating the mitochondrial thioredoxin, TRX1. Mol Cell (2011) 42:597-609. doi:10.1016/j.molcel.2011.03.030.
290. Horak P, Crawford AR, Vadysirisack DD, Nash ZM, DeYoung MP, Sgroi D, et al. Negative feedback control of HIF-1 through REDD1-regulated ROS suppresses tumorigenesis. Proc Natl Acad Sci U S A (2010) 107:4675-80. doi:10.1073/pnas.0907705107.
291. Bergers G, Benjamin LE. Tumorigenesis and the angiogenic switch. Nat Rev Cancer (2003) 3:401-10. doi:10.1038/nrc1093.
292. Erler JT, Bennewith KL, Nicolau M, Dornhofer N, Kong C, Le QT, et al. Lysyl oxidase is essential for hypoxia-induced metastasis. Nature (2006) 440:1222-6. doi:10.1038/nature04695.
293. Yang MH, Wu KJ. TWIST activation by hypoxia inducible factor-1 (HIF-1). Cell Cycle (2008) 7:2090-6. doi:10.4161/cc.7.14.6324.
294. Dewhirst MW, Cao Y, Moeller BJ. Cycling hypoxia and free radicals regulate angiogenesis and radiotherapy response. Nat Rev Cancer (2008) 8:425-37. doi:10.1038/nrc2397.
295. Semenza GL. Hypoxia-inducible factors in physiology and medicine. Cell (2012) 148:399-408. doi:10.1016/j.cell.2012.01.021.
296. Keith B, Johnson RS, Simon MC. HIF-1a and HIF-2a: sibling rivalry in hypoxic tumour growth and progression. Nat Rev Cancer (2012) 12:9-22. doi:10.1038/nrc3183.
297. Fu Z, Tindall DJ. FOXOs, cancer and regulation of apoptosis. Oncogene (2008) 27:2312-9. doi:10.1038/onc.2008.24.
298. Kops GJPL, Dansen TB, Polderman E, Saarloos I, Wirtz KWA, Coffer PJ, et al. Forkhead transcription factor FOXO3a protects quiescent cells from oxidative stress. Nature (2002) 419:316-21. doi:10.1038/nature01036.
299. Owusu-Ansah E, Yavari A, Mandal S, Banerjee U. Distinct mitochondrial retrograde signals control the G1-S cell cycle checkpoint. Nat Genet (2008) 40:356-61. doi:10.1038/ng.2007.50.
300. Ferber EC, Peck B, Delpuech O, Bell GP, East P, Schulze A. FOXO3a regulates reactive oxygen metabolism by inhibiting mitochondrial gene expression. Cell Death Differ (2012) 19:968-79. doi:10.1038/cdd.2011.179.
301. Jensen KS, Binderup T, Jensen KT, Therkelsen I, Borup R, Nilsson E, et al. FoxO3A promotes metabolic adaptation to hypoxia by antagonizing Myc function. EMBO J (2011) 30:4554-70. doi:10.1038/emboj.2011.323.
302. Peck B, Ferber EC, Schulze A. Antagonism between FOXO and MYC regulates cellular powerhouse. Front Oncol (2013) 3:96. doi:10.3389/fonc.2013.00096.
303. Hayes JD, McMahon M. NRF2 and KEAP1 mutations: permanent activation of an adaptive response in cancer. Trends Biochem Sci (2009) 34:176-88. doi:10.1016/j.tibs.2008.12.008.
304. Itoh K, Chiba T, Takahashi S, Ishii T, Igarashi K, Katoh Y, et al. An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. Biochem Biophys Res Commun (1997) 236:313-22. doi:10.1006/bbrc.1997.6943.
305. Komatsu M, Kurokawa H, Waguri S, Taguchi K, Kobayashi A, Ichimura Y, et al. The selective autophagy substrate p62 activates the stress responsive transcription factor Nrf2 through inactivation of Keap1. Nat Cell Biol (2010) 12:213-23. doi:10.1038/ncb2021.
306. Lau A, Wang XJ, Zhao F, Villeneuve NF, Wu T, Jiang T, et al. A noncanonical mechanism of Nrf2 activation by autophagy deficiency: direct interaction between Keap1 and p62. Mol Cell Biol (2010) 30:3275-85. doi:10.1128/MCB.00248-10.
307. Mitsuishi Y, Taguchi K, Kawatani Y, Shibata T, Nukiwa T, Aburatani H, et al. Nrf2 redirects glucose and glutamine into anabolic pathways in metabolic reprogramming. Cancer Cell (2012) 22:66-79. doi:10.1016/j.ccr.2012.05.016.
308. DeNicola GM, Karreth FA, Humpton TJ, Gopinathan A, Wei C, Frese K, et al. Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis. Nature (2011) 475:106-9. doi:10.1038/nature10189.
309. Shibata T, Ohta T, Tong KI, Kokubu A, Odogawa R, Tsuta K, et al. Cancer related mutations in NRF2 impair its recognition by Keap1-Cul3 E3 ligase and promote malignancy. Proc Natl Acad Sci U S A (2008) 105:13568-73. doi:10.1073/pnas.0806268105.
310. Singh A, Misra V, Thimmulappa RK, Lee H, Ames S, Hoque MO, et al. Dysfunctional KEAP1-NRF2 interaction in non-small-cell lung cancer. PLoS Med (2006) 3:e420. doi:10.1371/journal.pmed.0030420.
311. Solis LM, Behrens C, Dong W, Suraokar M, Ozburn NC, Moran CA, et al. Nrf2 and Keap1 abnormalities in non-small cell lung carcinoma and association with clinicopathologic features. Clin Cancer Res (2010) 16:3743-53. doi:10.1158/1078-0432.CCR-09-3352.
312. Hardie DG. AMP-activated protein kinase-an energy sensor that regulates all aspects of cell function. Genes Dev (2011) 25:1895-908. doi:10.1101/gad.17420111.
313. Mihaylova MM, Shaw RJ. The AMPK signaling pathway coordinates cell growth, autophagy and metabolism. Nat Rev Cell Biol (2011) 13:1016-23. doi:10.1038/ncb2329.
314. Jäger S, Handschin C, St-Pierre J, Spiegelman BM. AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1alpha. Proc Natl Acad Sci U S A (2007) 104:12017-22. doi:10.1073/pnas.0705070104.
315. Zong H, Ren JM, Young LH, Pypaert M, Mu J, Birnbaum MJ, et al. AMP kinase is required for mitochondrial biogenesis in skeletal muscle in response to chronic energy deprivation. Proc Natl Acad Sci U S A (2002) 99:15983-7. doi:10.1073/pnas.252625599.
316. Egan DF, Shackelford DB, Mihaylova MM, Gelino S, Kohnz RA, Mair W, et al. Phosphorylation of ULK1 (hATG1) by AMP-activated protein kinase connects energy sensing to mitophagy. Science (2011) 331:456-61. doi:10.1126/science.1196371.
317. Kim J, Kundu M, Viollet B, Guan KL. AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nat Cell Biol (2011) 13:132-41. doi:10.1038/ncb2152.
318. Sack MN, Finkel T. Mitochondrial metabolism, sirtuins and aging. Cold Spring Harb Perspect Biol (2012) 4:1-10. doi:10.1101/cshperspect.a013102.
319. Verdin E, Hirschey MD, Finley LWS, Haigis MC. Sirtuin regulation of mitochondria-energy production, apoptosis, and signaling. Trends Biochem Sci (2010) 35:669-75. doi:10.1016/j.tibs.2010.07.003.
320. Canto C, Auwerx J. Interference between PARPs and SIRT1: a novel approach to healthy ageing? Aging (2011) 3:543-7.
321. Lee IH, Cao L, Mostoslavsky R, Lombard DB, Liu J, Bruns NE, et al. A role for the NAD-dependent deacetylase Sirt1 in the regulation of autophagy. Proc Natl Acad Sci U S A (2008) 105:3374-9. doi:10.1073/pnas.0712145105.
322. Alto NM, Soderling J, Scott JD. Rab32 is an A-kinase anchoring protein and participates in mitochondrial dynamics. J Cell Sci (2002) 158:659-68. doi:10.1083/jcb.200204081.
323. Bera AK, Ghosh S, Das S. Mitochondrial VDAC can be phosphorylated by cyclic AMP-dependent protein kinase. Biochem Biophys Res Commun (1995) 209:213-7. doi:10.1006/bbrc.1995.1491.
324. Das S, Wong R, Rajapakse N, Murphy E, Steenbergen C. Glycogen synthase kinase 3 inhibition slows mitochondrial adenine nucleotide transport and regulates voltage-dependent anion channel phosphorylation. Circ Res (2008) 103:983-91. doi:10.1161/CIRCRESAHA.108.178970.
325. Juhaszova M, Zorov DB, Kim SH, Pepe S, Fu Q, Fishbein KW, et al. Glycogen synthase kinase-3beta mediates convergence of protection signaling to inhibit the mitochondrial permeability transition pore. J Clin Invest (2004) 113:1535-49. doi:10.1172/JCI200419906.
326. Kumar S, Bharti A, Mishra NC, Raina D, Kharbanda S, Saxena S, et al. Targeting of the c-Abl tyrosine kinase to mitochondria in the necrotic cell death response to oxidative stress. J Biol Chem (2001) 276:17281-5. doi:10.1074/jbc.M101414200.
327. Majumder PK, Mishra NC, Sun X, Bharti A, Kharbanda S, Saxena S, et al. Targeting of protein kinase C delta to mitochondria in the oxidative stress response. Cell Growth Differ (2001) 12:465-70.
328. Robey RB, Hay N. Is Akt the "Warburg kinase"?-Akt energy metabolism interactions and oncogenesis. Semin Cancer Biol (2009) 19:25-31. doi:10.1016/j.semcancer.2008.11.010.
329. Manning BD, Cantley LC. AKT/PKB signaling: navigating downstream. Cell (2007) 129:1261-74. doi:10.1016/j.cell.2007.06.009.
330. Patra KC, Wang QJ, Bhaskar PT, Miller L, Wang Z, Chandel NS, et al. Hexokinase 2 is required for tumor initiation and maintenance and its systemic deletion is therapeutic in mouse models of cancer. Cancer Cell (2013) 24:213-28. doi:10.1016/j.ccr.2013.06.014.
331. Maurer U, Chavret C, Wagman AS, Dejardin E, Green DR. Glycogen synthase kinase-3 regulates mitochondrial outer membrane permeabilization and apoptosis by destabilization of MCL-1. Mol Cell (2006) 21:749-60. doi:10.1016/j.molcel.2006.02.009.
332. Sheldon KL, Maldonado EN, Lemasters JJ, Rostovtseva TK, Bezrukov SM. Phosphorylation of voltage-dependent anion channel by serine/threonine kinases governs its interaction with tubulin. PLoS One (2011) 6:e25539. doi:10.1371/journal.pone.0025539.
333. Martel C, Allouche M, Esposti DD, Fanelli E, Boursier C, Henry C, et al. Glycogen synthase kinase 3-mediated voltage-dependent anion channel phosphorylation controls outer mitochondrial membrane permeability during lipid accumulation. Hepatology (2013) 57:93-102. doi:10.1002/hep.25967.
334. Chou CH, Lin CC, Yang MC, Wei CC, Liao HD, Lin RC, et al. GSK3beta-mediated Drp1 phosphorylation induced elongated mitochondrial morphology against oxidative stress. PLoS One (2012) 7:e49112. doi:10.1371/journal.pone.0049112.
335. Diehl JA, Cheng M, Roussel MF, Sherr CJ. Glycogen synthase kinase-3 beta regulates cyclin D1 proteolysis and subcellular localisation. Genes Dev (1998) 12:3499-511.
336. Rubinfeld B, Albert I, Porfiri E, Fiol C, Munemitsu S, Polakis P. Binding of GSK3B to the APC-b-catenin complex and regulation of complex assembly. Science (1996) 272:1023-6. doi:10.1126/science.272.5264.1023.
337. Sears R, Nuckolls F, Haura E, Taya Y, Tamai K, Nevins JR. Multiple Ras-dependent phosphorylation pathways regulate Myc protein stability. Genes Dev (2000) 14:1-14.
338. Yeh E, Cunningham M, Arnold H, Chasse D, Monteith T, Ivaldi G, et al. A signalling pathway controlling c-Myc degradation that impacts oncogenic transformation of human cells. Nat Cell Biol (2004) 6:308-18. doi:10.1038/ncb1110.
339. Ilouz R, Bubis J, Wu J, Yim YY, Deal MS, Kornev AP, et al. Localization and quaternary structure of the PKA RIβ holoenzyme. Proc Natl Acad Sci U S A (2012) 109:12443-8. doi:10.1073/pnas.1209538109.
340. Means CK, Lygren B, Langeberg LK, Jain A, Dixon RE, Vega AL, et al. An entirely specific type I A-kinase anchoring protein that can sequester two molecules of protein kinase A at mitochondria. Proc Natl Acad Sci U S A (2011) 108:1227-35. doi:10.1073/pnas.1107182108.
341. Carlucci A, Adornetto A, Scorziello A, Viggiano D, Foca M, Cuomo O, et al. Proteolysis of AKAP121 regulates mitochondrial activity during cellular hypoxia and brain ischaemia. EMBO J (2008) 27:1073-84. doi:10.1038/emboj.2008.33.
342. Livigni A, Scorziello A, Agnese S, Adornetto A, Carlucci A, Garbi C, et al. Mitochondrial AKAP121 links cAMP and src signaling to oxidative metabolism. Mol Biol Cell (2006) 17:263-71. doi:10.1091/mbc.E05-09-0827.
343. Miyazaki T, Neff L, Tanaka S, Horne WC, Baron R. Regulation of cytochrome c oxidase activity by c-Src in osteoclasts. J Cell Biol (2003) 160:709-18. doi:10.1083/jcb.200209098.
344. Tibaldi E, Brunati AM, Massimino ML, Stringaro A, Colone M, Agostinelli E, et al. Src-Tyrosine kinases are major agents in mitochondrial tyrosine phosphorylation. J Cell Biochem (2008) 104:840-9. doi:10.1002/jcb.21670.
345. Jeon SM, Chandel NS, Hay N. AMPK regulates NADPH homeostasis to promote tumour cell survival during energy stress. Nature (2012) 485:661-5. doi:10.1038/nature11066.
346. Valentin-Vega YA, MacLean KH, Tait-Mulder J, Milasta S, Steeves M, Dorsey FC, et al. Mitochondrial dysfunction in ataxia-telangiectasia. Blood (2012) 119:1490-500. doi:10.1182/blood-2011-08-373639.
347. Compton S, Kim C, Griner NB, Potluri P, Scheffler IE, Sen S, et al. Mitochondrial dysfunction impairs tumor suppressor p53 expression/function. J Biol Chem (2011) 286:20297-312. doi:10.1074/jbc.M110.163063.
348. Muller PAJ, Vousden KH. p53 mutations in cancer. Nat Cell Biol (2013) 15:2-8. doi:10.1038/ncb2641.
349. Vousden KH, Prives C. Blinded by the light: the growing complexity of p53. Cell (2009) 137:413-31. doi:10.1016/j.cell.2009.04.037.
350. Bieging KT, Attardi LD. Deconstructing p53 transcriptional networks in tumor suppression. Trends Cell Biol (2012) 22:97-106. doi:10.1016/j.tcb.2011.10.006.
351. Vousden KH, Lu X. Live or let die: the cell's response to p53. Nat Rev Cancer (2002) 2:594-604. doi:10.1038/nrc864.
352. Brugarolas J, Chandrasekaran C, Gordon JI, Beach D, Jacks T, Hannon GJ. Radiation-induced cell cycle arrest compromised by p21 deficiency. Nature (1995) 377:552-7. doi:10.1038/377552a0.
353. Marchenko ND, Zaika A, Moll UM. Death signal-induced localization of p53 protein to mitochondria. J Biol Chem (2000) 275:16202-12. doi:10.1074/jbc.275.21.16202.
354. Mihara M, Erster S, Zaika A, Petrenko O, Chittenden T, Pancoska P, et al. p53 has a direct apoptogenic role at the mitochondria. Mol Cell (2003) 11:577-90. doi:10.1016/S1097-2765(03)00050-9.
355. Crighton D, Wilkinson S, O'Prey J, Syed N, Smith P, Harrison PR, et al. DRAM, a p53-induced modulator of autophagy, is critical for apoptosis. Cell (2006) 126:121-34. doi:10.1016/j.cell.2006.05.034.
356. Kenzelmann Broz D, Spano Mello S, Bieging KT, Jiang D, Dusek RL, Brady CA, et al. Global genomic profiling reveals an extensive p53-regulated autophagy program contributing to key p53 responses. Genes Dev (2013) 27:1016-31. doi:10.1101/gad.212282.112.
357. Vousden KH, Ryan KM. p53 and metabolism. Nat Rev Cancer (2009) 9:691-700. doi:10.1038/nrc2715.
358. Tasdemir E, Maiuri MC, Galluzzi L, Vitale I, Djavaheri-Mergny M, D'Amelio M, et al. Regulation of autophagy by cytoplasmic p53. Nat Cell Biol (2008) 10:676-87. doi:10.1038/ncb1730.
359. Matoba S, Kang JG, Patino WD, Wragg A, Boehm M, Gavrilova O, et al. p53 regulates mitochondrial respiration. Science (2006) 312:1650-3. doi:10.1126/science.1126863.
360. Jiang P, Du W, Mancuso A, Wellen KE, Yang X. Reciprocal regulation of p53 and malic enzymes modulates metabolism and senescence. Nature (2013) 493:689-93. doi:10.1038/nature11776.
361. Bensaad K, Tsuruta A, Selak MA, Vidal MNC, Nakano K, Bartrons R, et al. TIGAR, a p53-inducible regulator of glycolysis and apoptosis. Cell (2006) 126:107-20. doi:10.1016/j.cell.2006.05.036.
362. Jones RG, Plas D, Kubek S, Buzzai M, Mu J, Xu Y, et al. AMP-activated protein kinase induces a p53-dependent metabolic checkpoint. Mol Cell (2005) 18:283-93. doi:10.1016/j.molcel.2005.03.027.
363. Zhou BP, Liao Y, Xia W, Zou Y, Spohn B, Hung MC. HER-2/neu induces p53 ubiquitination via Akt-mediated MDM2 phosphorylation. Nat Cell Biol (2001) 3:973-82. doi:10.1038/35060032.
364. Chipuk JE, Bouchier-Hayes L, Kuwana T, Newmeyer DD, Green DR. PUMA couples the nuclear and cytoplasmic proapoptotic function of p53. Science (2005) 309:1732-5. doi:10.1126/science.1114297.
365. Vaseva AV, Marchenko ND, Ji K, Tsirka SE, Holzmann S, Moll UM. p53 opens the mitochondrial permeability transition pore to trigger necrosis. Cell (2012) 149:1536-48. doi:10.1016/j.cell.2012.05.014.
366. Sherr CJ, McCormick F. The RB and p53 pathways in cancer. Cancer Cell (2002) 2:103-12. doi:10.1016/S1535-6108(02)00102-2.
367. Weinberg RA. The retinoblastoma protein and cell cycle control. Cell (1995) 81:323-30. doi:10.1016/0092-8674(95)90385-2.
368. MacLeod KF. The RB tumor suppressor: a gatekeeper to hormone independence in prostate cancer? J Clin Invest (2010) 120:4179-82. doi:10.1172/JCI45406.
369. Sharma A, Yeow WS, Ertel A, Coleman I, Thangavel C, Cornstock CES, et al. Novel functions of the retinoblastoma tumor suppressor in controlling androgen signaling and prostate cancer progression. J Clin Invest (2010) 120:4478-92. doi:10.1172/JCI44239.
370. Burkhart DL, Sage J. Cellular mechanisms of tumour suppression by the retinoblastoma gene. Nat Rev Cancer (2008) 8:1-12. doi:10.1038/nrc2399.
371. MacLeod KF. The role of the RB tumor suppressor pathway in oxidative stress responses in the hematopoietic system. Nat Rev Cancer (2008) 8:769-81. doi:10.1038/nrc2504.
372. Narita M, Nunez S, Heard E, Narita M, Lin AW, Hearn SA, et al. Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence. Cell (2003) 113:703-16. doi:10.1016/S0092-8674(03)00401-X.
373. Sage J, Miller AL, Perez-Mancera PA, Wysocki JM, Jacks T. Acute mutation of retinoblastoma gene function is sufficient for cell cycle re-entry. Nature (2003) 424:223-8. doi:10.1038/nature01764.
374. Chen HZ, Tsai SY, Leone G. Emerging roles of E2Fs in cancer: an exit from cell cycle control. Nat Rev Cancer (2009) 9:785-97. doi:10.1038/nrc2696.
375. Chong JL, Wenzel PL, Saenz-Robles MT, Nair V, Ferrey A, Hagan JP, et al. E2f1-3 switch from activators in progenitor cells to repressors in differentiating cells. Nature (2009) 462:930-4. doi:10.1038/nature08677.
376. Dirlam A, Spike BT, MacLeod KF. De-regulated E2f-2 activity underlies cell cycle and maturation defects in Rb null erythroblasts. Mol Cell Biol (2007) 27:8713-28. doi:10.1128/MCB.01118-07.
377. Fajas L, Egler V, Reiter R, Miard S, Lefebvre AM, Auwerx J. PPARg controls cell proliferation and apoptosis in an RB-dependent manner. Onocgene (2003) 22:4186-93. doi:10.1038/sj.onc.1206530.
378. Fajas L, Landsberg RL, Huss-Garcia Y, Sardet C, Lees JA, Auwerx J. E2Fs regulate adipocyte differentiation. Dev Cell (2002) 3:39-49. doi:10.1016/S1534-5807(02)00190-9.
379. Sankaran VG, Orkin SH, Walkley CR. Rb intrinsically promotes erythropoiesis by coupling cell cycle exit with mitochondrial biogenesis. Genes Dev (2008) 22:463-75. doi:10.1101/gad.1627208.
380. Chau BN, Wang JYJ. Coordinated regulation of life and death by RB. Nat Rev Cancer (2003) 3:130-8. doi:10.1038/nrc993.
381. Aguilar V, Fajas L. Cycling through metabolism. EMBO Mol Med (2010) 2:338-48. doi:10.1002/emmm.201000089.
382. Hsieh MCF, Das D, Sambandam N, Zhang MQ, Nahle Z. Regulation of the PDK4 isozyme by the RB-E2F1 complex. J Biol Chem (2008) 283:27410-7. doi:10.1074/jbc.M802418200.
383. Lopez-Bigas N, Kisiel TA, DeWaal DC, Holmes KB, Volkert TL, Gupta S, et al. Genome-wide analysis of the H3K4 histone demethylase RBP2 reveals a transcriptional program controlling differentiation. Mol Cell (2008) 31:520-30. doi:10.1016/j.molcel.2008.08.004.
384. Blanchet E, Annicotte JS, Lagarrigue S, Aguilar V, Clapé C, Chavey C, et al. E2F transcription factor-1 regulates oxidative metabolism. Nat Cell Biol (2011) 13:1146-52. doi:10.1038/ncb2309.
385. Ferecatu I, Le Floch N, Bergeaud M, Rodriguez-Enfedaque A, Rincheval V, Oliver L, et al. Evidence for a mitochondrial localization of the retinoblastoma protein. BMC Cell Biol (2009) 10:50. doi:10.1186/1471-2121-10-50.
386. Hilgendorf KI, Leshchiner ES, Nedelcu S, Maynard MA, Calo E, Ianari A, et al. The retinoblastoma protein induces apoptosis directly at the mitochondria. Genes Dev (2013) 27:1-13. doi:10.1101/gad.211326.112.
387. Wang J, Xie LY, Allan S, Beach D, Hannon GJ. Myc activates telomerase. Genes Dev (1998) 12:1769-74.
388. Gordan JD, Bertout JA, Hu CJ, Diehl JA, Simon MC. HIF-2a promotes hypoxic cell proliferation by enhancing c-Myc transcriptional activity. Cancer Cell (2007) 11:335-47. doi:10.1016/j.ccr.2007.02.006.
389. Koshiji M, To KKW, Hammer S, Kumamoto K, Harris AL, Modrich P, et al. HIF-1a induces genetic instability by transcriptionally downregulating Mutsa expression. Mol Cell (2005) 17:793-803. doi:10.1016/j.molcel.2005.02.015.
390. Johnson SA, Dubeau L, Johnson DL. Enhanced RNA polymerase III-dependent transcription is required for oncogenic transformation. J Biol Chem (2008) 283:19184-91. doi:10.1074/jbc.M802872200.
391. Liu H, Radisky DC, Yang D, Xu R, Radisky ES, Bissell MJ, et al. MYC suppresses cancer metastasis by direct transcriptional silencing of αv and β3 integrin subunits. Nat Cell Biol (2012) 14:567-74. doi:10.1038/ncb2491.
392. Baudino TA, McKay C, Pendeville-Samain H, Nilsson JA, MacLean KH, White EL, et al. c-Myc is essential for vasculogenesis and angiogenesis during development and tumor progression. Genes Dev (2002) 16:2530-43.
393. Sodir NM, Swigart LB, Karnezis AN, Hanahan D, Evan GI, Soucek L. Endogenous Myc maintains the tumor microenvironment. Genes Dev (2011) 25:907-16. doi:10.1101/gad.2038411.
394. Shim H, Chun YS, Lewis BC, Dang CV. A unique glucose-dependent apoptotic pathway induced by c-Myc. Proc Natl Acad Sci U S A (1998) 95:1511-6. doi:10.1073/pnas.95.4.1511.
395. Soucek L, Whitfield J, Martins CP, Finch AJ, Murphy DJ, Sodir NM, et al. Modelling Myc inhibition as a cancer therapy. Nature (2008) 455:679-83. doi:10.1038/nature07260.
396. Soucek L, Whitfield JR, Sodir NM, Massó-Vallés D, Serrano E, Karnezis AN, et al. Inhibition of Myc family proteins eradicates KRas-driven lung cancer in mice. Genes Dev (2013) 27:504-12. doi:10.1101/gad.205542.112.
397. Gao P, Tchernyshyov I, Chang TC, Lee YS, Kita K, Ochi T, et al. c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism. Nature (2009) 458:762-5. doi:10.1038/nature07823.
398. Wise DR, DeBerardinis RJ, Mancuso A, Sayed N, Zhang XY, Pfeiffer HK, et al. Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction. Proc Natl Acad Sci U S A (2008) 105:18782-7. doi:10.1073/pnas.0810199105.
399. Yuneva M, Zamboni N, Oefner P, Sachidanandam R, Lazebnik Y. Deficiency in glutamine but not glucose induces MYC-dependent apoptosis in human cells. J Cell Biol (2007) 178:93-105. doi:10.1083/jcb.200703099.
400. Qing G, Li B, Vu A, Skuli N, Walton ZE, Liu X, et al. ATF4 regulates MYC-mediated neuroblastoma cell death upon glutamine deprivation. Cancer Cell (2012) 22:631-44. doi:10.1016/j.ccr.2012.09.021.
401. Liu L, Ulbrich J, Müller J, Wüstefeld T, Aeberhard L, Kress TR, et al. Deregulated MYC expression induces dependence upon AMPK-related kinase 5. Nature (2012) 483:608-12. doi:10.1038/nature10927.
402. Koshiji M, Kageyama Y, Pete EA, Horikawa I, Barrett JC, Huang LE. HIF-1a induces cell cycle arrest by functionally counteracting Myc. EMBO J (2004) 23:1949-56. doi:10.1038/sj.emboj.7600196.
403. American CS. Cancer Facts & Figures 2011. (2011). Available at: http://www.cancer.org/acs/groups/content/@epidemiologysurveilance/documents/document/acspc-029771.pdf.
404. Ying H, Kimmelman AC, Lyssiotis CA, Hua S, Chu GC, Fletcher-Sananikone E, et al. Oncogenic Kras maintains pancreatic tumors through regulation of anabolic glucose metabolism. Cell (2012) 149:656-70. doi:10.1016/j.cell.2012.01.058.
405. Son J, Lyssiotis CA, Ying H, Wang X, Hua S, Ligorio M, et al. Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway. Nature (2013) 496:101-5. doi:10.1038/nature12040.
406. Hu S, Balakrishnan A, Bok RA, Anderton B, Larson PEZ, Nelson SJ, et al. 13C-pyruvate imaging reveals alterations in glycolysis that precede cMyc-induced tumor formation and regression. Cell Metab (2011) 14:131-42. doi:10.1016/j.cmet.2011.04.012.
407. Baracca A, Chiaradonna F, Sgarbi G, Solaini G, Alberghina L, Lenaz G. Mitochondrial complex I decrease is responsible for bioenergetic dysfunction in K-ras transformed cells. Biochim Biophys Acta (2010) 1797:314-23. doi:10.1016/j.bbabio.2009.11.006.
408. Sears R, Leone G, DeGregori J, Nevins JR. Ras enhances Myc protein stability. Mol Cell (1999) 3:169-79. doi:10.1016/S1097-2765(00)80308-1.